campaign_id,campaign_channel,content_id,content,dominant_topic,topic_0,topic_1,topic_2,topic_3,topic_4,topic_5,topic_6,topic_7,topic_8,topic_9,specialty
CMP_1,in-person,C0000,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.0004003187,0.00058433606,0.20502715,0.00050731376,0.00054102467,0.12990241,0.1873738,0.0006033033,0.00046935194,0.474591,Cardiology
CMP_2,rep_visit,C0001,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.00044007343,0.00064236496,0.00044564498,0.0005576939,0.0005947526,0.9947356,0.00064954284,0.0006632159,0.0005159622,0.0007551454,General Practice
CMP_3,social-event,C0002,health care healthcare self model include factor intervention management medical,1,0.0016923993,0.53225994,0.44880128,0.0021447346,0.002287252,0.0028775954,0.0024979608,0.0025505426,0.001984246,0.0029040775,Family Medicine
CMP_4,rep_visit,C0003,thyroid disorder woman hormone disease hypothyroidism association pregnancy tsh level,0,0.54662895,0.2719519,0.0005720167,0.00071583944,0.00076340686,0.0009604448,0.17592463,0.0008512843,0.0006622738,0.00096928375,Endocrinology
CMP_5,rep_visit,C0004,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.2091262,0.0046370085,0.0032169544,0.0040257964,0.0042933105,0.36641833,0.0046888217,0.3944179,0.0037245497,0.0054511274,General Practice
CMP_6,rep_visit,C0005,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.00020274194,0.00029593776,0.29569355,0.00025692972,0.00027400267,0.5905724,0.00029924457,0.11181963,0.0002377039,0.000347896,General Practice
CMP_7,webinar,C0006,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.00033333022,0.00048655452,0.21595162,0.00042242094,0.00045049077,0.000566763,0.00049199135,0.78033406,0.00039081156,0.0005719801,General Practice
CMP_8,rep_visit,C0007,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0003509484,0.0005122713,0.00035539156,0.000444748,0.09541548,0.5019958,0.0005179955,0.3993937,0.00041146792,0.00060221105,General Practice
CMP_9,email,C0008,thyroid disorder drug infection role include relate adverse function gut,4,0.00048867526,0.00071330817,0.44238162,0.0006192858,0.45934322,0.0008308964,0.0007212787,0.09349015,0.00057294517,0.0008385444,Internal Medicine
CMP_10,webinar,C0009,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0015598708,0.002276907,0.0015796195,0.0019767846,0.0021081418,0.98134,0.002302349,0.0023508144,0.0018288636,0.00267666,General Practice
CMP_11,in-person,C0010,health care healthcare self model include factor intervention management medical,1,0.00029617333,0.63312024,0.000299923,0.00037533292,0.0004002738,0.36376914,0.0004371482,0.00044635017,0.0003472471,0.00050821993,Family Medicine
CMP_12,rep_visit,C0011,risk age factor high year disease prevalence associate cardiovascular group,6,0.00033055918,0.07939486,0.00033474423,0.00041890927,0.00044674575,0.11961878,0.7980024,0.0004981716,0.00038756267,0.000567224,General Practice
CMP_13,webinar,C0012,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.00030999025,0.0004524856,0.00031391488,0.00039284278,0.3398165,0.11972652,0.00045754173,0.5376348,0.0003634467,0.00053192885,General Practice
CMP_14,rep_visit,C0013,risk age factor high year disease prevalence associate cardiovascular group,6,0.0016924508,0.0024704318,0.0017138781,0.0021448,0.11212583,0.0028776831,0.73587316,0.00255062,0.0019843066,0.13656685,General Practice
CMP_15,webinar,C0014,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.0027397615,0.003999167,0.0027744481,0.0034720302,0.46526265,0.004658432,0.004043854,0.50513613,0.0032122214,0.004701303,General Practice
CMP_16,social-event,C0015,treatment use respiratory cancer type therapy clinical need care obesity,2,0.00033055994,0.00048251072,0.9283182,0.00041891023,0.00044674677,0.06806218,0.00048790238,0.0004981729,0.00038756354,0.0005672252,General Practice
CMP_17,rep_visit,C0016,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.00040851967,0.0005963068,0.0004136917,0.114429794,0.00055210816,0.3561786,0.25170714,0.0006156626,0.0004789671,0.27461922,General Practice
CMP_18,social-event,C0017,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.0017674402,0.0025798925,0.0017898169,0.5115766,0.0023886687,0.46952012,0.0026087193,0.002663633,0.0020722277,0.0030328399,Family Medicine
CMP_19,webinar,C0018,thyroid disorder drug infection role include relate adverse function gut,4,0.0015598936,0.002276941,0.0015796425,0.0019768137,0.618565,0.0026522952,0.0023023838,0.36458144,0.0018288904,0.0026767098,Internal Medicine
CMP_20,webinar,C0019,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.00030999206,0.00045248828,0.00031391668,0.00039284505,0.15787095,0.73961824,0.00045754432,0.00046717582,0.0003634488,0.099753425,General Practice
CMP_21,webinar,C0020,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0024085054,0.0035156403,0.0024389983,0.20487952,0.0032550585,0.76936084,0.0035549242,0.0036297566,0.0028238418,0.0041328827,General Practice
CMP_22,webinar,C0021,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.000541822,0.0007908851,0.19568399,0.00068663724,0.00073226425,0.000921263,0.0007997225,0.7982784,0.0006352568,0.0009297404,General Practice
CMP_23,in-person,C0022,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.00032253857,0.00047080222,0.00032662207,0.00040874496,0.00043590603,0.829701,0.00047608305,0.0004860843,0.00037815896,0.16699402,General Practice
CMP_24,in-person,C0023,health care healthcare self model include factor intervention management medical,1,0.0010903769,0.558401,0.0011041816,0.001381807,0.0014736279,0.43014693,0.0016093823,0.0016432605,0.0012784076,0.0018710342,Family Medicine
CMP_25,in-person,C0024,health care healthcare self model include factor intervention management medical,1,0.0024085399,0.50646764,0.002439033,0.0030522814,0.003255105,0.0040952465,0.003554974,0.4677703,0.002823882,0.004132962,Family Medicine
CMP_26,rep_visit,C0025,health care healthcare self model include factor intervention management medical,1,0.0010903549,0.6704804,0.0011041593,0.001381779,0.0014735981,0.3180678,0.0016093499,0.0016432271,0.0012783818,0.0018709975,Family Medicine
CMP_27,rep_visit,C0026,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0013486966,0.21885182,0.0013657717,0.001709169,0.0018227431,0.60461074,0.0019906594,0.0020325636,0.0015812735,0.16468653,General Practice
CMP_28,rep_visit,C0027,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.001767463,0.002579925,0.46109378,0.002239861,0.0023886994,0.5195527,0.002608753,0.002663668,0.0020722542,0.00303289,General Practice
CMP_29,in-person,C0028,thyroid disorder drug infection role include relate adverse function gut,4,0.00048275138,0.00070466107,0.0004888632,0.0006117786,0.6034122,0.39146525,0.000712535,0.00072753424,0.0005659997,0.0008283789,Internal Medicine
CMP_30,social-event,C0029,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0016925948,0.002470642,0.0017140239,0.0021449826,0.0022875164,0.9223722,0.059878312,0.0025508371,0.0019844754,0.0029044168,General Practice
CMP_31,email,C0030,health care healthcare self model include factor intervention management medical,1,0.0015599285,0.40248668,0.31962654,0.001976858,0.0021082198,0.0026523569,0.2627328,0.0023509015,0.0018289314,0.0026767685,Family Medicine
CMP_32,social-event,C0031,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.02579997,0.03765961,0.026126608,0.032695647,0.034868266,0.043867666,0.03808042,0.68638134,0.030249061,0.04427142,General Practice
CMP_33,social-event,C0032,risk age factor high year disease prevalence associate cardiovascular group,6,0.0011879422,0.0017340123,0.0012029822,0.22027889,0.001605486,0.10949598,0.45279354,0.0017902973,0.20787247,0.0020384558,General Practice
CMP_34,webinar,C0033,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0027396628,0.0039990228,0.15573746,0.0034719054,0.0037026128,0.8142635,0.0040437076,0.0041288286,0.0032121057,0.004701137,General Practice
CMP_35,rep_visit,C0034,thyroid disorder drug infection role include relate adverse function gut,4,0.0004400861,0.0006423835,0.0004456578,0.00055770995,0.6743349,0.21849638,0.0006495615,0.011816675,0.000515977,0.09210067,Internal Medicine
CMP_36,social-event,C0035,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.00029182804,0.26216227,0.0002955227,0.00036982627,0.00039440117,0.0004961962,0.00043073457,0.734715,0.00034215252,0.0005020284,General Practice
CMP_37,social-event,C0036,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.12315251,0.001010831,0.0007012706,0.00087759166,0.0009359076,0.11391009,0.0010221258,0.43727553,0.0008119223,0.32030228,General Practice
CMP_38,email,C0037,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.000758424,0.0011070542,0.000768026,0.0009611315,0.25167838,0.7402739,0.0011194241,0.0011429883,0.0008892109,0.0013014242,General Practice
CMP_39,in-person,C0038,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.00022071281,0.00032216945,0.00022350714,0.45139632,0.00029829005,0.00037527923,0.38766432,0.15886188,0.00025877377,0.00037873304,Family Medicine
CMP_40,rep_visit,C0039,risk age factor high year disease prevalence associate cardiovascular group,6,0.0019395682,0.002831143,0.0019641242,0.0024579656,0.002621297,0.15427896,0.5923597,0.0029230407,0.235296,0.003328209,General Practice
CMP_41,social-event,C0040,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.0005648533,0.00082450325,0.0005720046,0.00071582425,0.0007633907,0.47238275,0.00083371636,0.5217114,0.00066225976,0.00096926175,General Practice
CMP_42,in-person,C0041,risk age factor high year disease prevalence associate cardiovascular group,6,0.001623507,0.002369796,0.0016440613,0.0020574292,0.0021941452,0.47895104,0.50402397,0.002446718,0.0019034736,0.0027858617,General Practice
CMP_43,social-event,C0042,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.025799971,0.037659615,0.02612661,0.032695647,0.034868266,0.04386767,0.03808042,0.6863813,0.030249063,0.044271424,General Practice
CMP_44,email,C0043,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0002918277,0.00042597414,0.00029552236,0.0003698258,0.0003944007,0.99650896,0.00043073395,0.0004398011,0.00034215208,0.0005007628,General Practice
CMP_45,email,C0044,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.0016923824,0.0024703313,0.0017138087,0.0021447134,0.0022872295,0.002877561,0.0024979352,0.97942775,0.0019842263,0.002904049,General Practice
CMP_46,email,C0045,health care healthcare self model include factor intervention management medical,1,0.00091509713,0.53227127,0.0009266827,0.0011596794,0.0012367399,0.4581176,0.0013506719,0.0013791037,0.0010729017,0.0015702634,Family Medicine
CMP_47,social-event,C0046,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0010076419,0.13427846,0.001020399,0.001276959,0.0013618127,0.70657825,0.15004739,0.0015185741,0.0011814053,0.0017290668,General Practice
CMP_48,rep_visit,C0047,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.0029418848,0.0042942013,0.0029791305,0.003728176,0.003975913,0.005002102,0.004342185,0.0044335895,0.0034492002,0.96485364,Cardiology
CMP_49,rep_visit,C0048,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0012632564,0.0018439464,0.0012792499,0.349516,0.001707272,0.49634528,0.0018645508,0.0019037998,0.0014810995,0.14279555,General Practice
CMP_50,social-event,C0049,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.00052745943,0.0007699204,0.00053413736,0.000668436,0.00071285345,0.0008968422,0.00077852356,0.00079491176,0.0006184175,0.9936985,Cardiology
CMP_51,rep_visit,C0050,health care healthcare self model include factor intervention management medical,1,0.0010903918,0.7801469,0.0011041966,0.0013818259,0.0014736481,0.2084008,0.001609405,0.0016432832,0.0012784251,0.001871062,Family Medicine
CMP_52,rep_visit,C0051,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.00089452823,0.0013057223,0.14788528,0.0011336129,0.0012089413,0.8423198,0.0013203124,0.0013481053,0.0010487858,0.0015349678,General Practice
CMP_53,rep_visit,C0052,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0007441844,0.001086269,0.00075360615,0.0009430861,0.001005754,0.9910976,0.001098407,0.0011215287,0.0008725158,0.0012769854,General Practice
CMP_54,webinar,C0053,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.0013487544,0.0019687458,0.0013658303,0.0017092422,0.0018228211,0.13826425,0.20293532,0.6466893,0.0015813411,0.0023144004,General Practice
CMP_55,email,C0054,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.000572976,0.47636545,0.00058023015,0.000726118,0.0007743684,0.00097423384,0.00084570545,0.0008635077,0.00067178323,0.51762563,Cardiology
CMP_56,webinar,C0055,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.0015011729,0.0021912276,0.0015201785,0.0019023983,0.0020288124,0.35285446,0.0022157128,0.15760733,0.0017600437,0.47641864,Cardiology
CMP_57,email,C0056,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.00052747503,0.000769943,0.0005341531,0.0006684557,0.10290993,0.00089686835,0.00077854656,0.8913911,0.00061843573,0.00090512284,General Practice
CMP_58,email,C0057,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.000520568,0.00075986097,0.0005271586,0.0006597026,0.00070353976,0.0008851243,0.0007683517,0.99367213,0.00061033765,0.0008932696,General Practice
CMP_59,email,C0058,treatment use respiratory cancer type therapy clinical need care obesity,2,0.0016234792,0.0023697552,0.9794627,0.002057394,0.0021941075,0.002760414,0.0023962357,0.0024466764,0.001903441,0.0027858173,General Practice
CMP_60,social-event,C0059,thyroid disorder drug infection role include relate adverse function gut,4,0.0018496357,0.002699873,0.001873053,0.0023439964,0.7370781,0.24329537,0.0027300399,0.0027875071,0.0021685974,0.0031738854,Internal Medicine
CMP_61,webinar,C0060,treatment use respiratory cancer type therapy clinical need care obesity,2,0.105343804,0.4259057,0.4522063,0.002057408,0.0021941224,0.0027604296,0.0023962513,0.002446693,0.001903454,0.0027858368,General Practice
CMP_62,email,C0061,health care healthcare self model include factor intervention management medical,1,0.0005009424,0.9938869,0.0005072846,0.0006348316,0.0006770161,0.0008517564,0.00073938485,0.0007549492,0.00058732776,0.0008595944,Family Medicine
CMP_63,in-person,C0062,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.00060797104,0.00088744133,0.00061566825,0.0007704663,0.00082166365,0.8514881,0.00089735753,0.0009162473,0.000712813,0.14228229,General Practice
CMP_64,rep_visit,C0063,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.00057299034,0.0008363808,0.36665696,0.00072613615,0.0007743878,0.00097425724,0.00084572646,0.62695813,0.0006718,0.0009832248,General Practice
CMP_65,webinar,C0064,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.00032784726,0.06211523,0.000331998,0.3904037,0.00044308061,0.5444532,0.00048389848,0.0004940847,0.0003843831,0.0005625705,General Practice
CMP_66,rep_visit,C0065,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.13639967,0.0014345768,0.0009952472,0.001245483,0.0013282453,0.8528263,0.001450607,0.0014811427,0.0011522847,0.0016864474,General Practice
CMP_67,webinar,C0066,health care healthcare self model include factor intervention management medical,1,0.0013487366,0.5467508,0.0013658123,0.0017092198,0.43861315,0.002293262,0.0019907188,0.0020326232,0.0015813203,0.0023143706,Family Medicine
CMP_68,webinar,C0067,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.00033900279,0.0004948346,0.00034329473,0.00042960962,0.00045815713,0.00057640724,0.00050036394,0.9958792,0.00039746234,0.0005817135,General Practice
CMP_69,email,C0068,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.02579997,0.03765961,0.026126608,0.032695647,0.034868266,0.043867666,0.03808042,0.68638134,0.030249061,0.04427142,General Practice
CMP_70,in-person,C0069,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.003778804,0.005515832,0.0038266454,0.0047887824,0.0051069963,0.9547959,0.005577467,0.005694875,0.004430442,0.006484248,General Practice
CMP_71,rep_visit,C0070,treatment use respiratory cancer type therapy clinical need care obesity,2,0.0004769655,0.00069621555,0.6356686,0.0006044463,0.00064461166,0.35910875,0.00070399506,0.0007188145,0.00055921613,0.00081845047,General Practice
CMP_72,webinar,C0071,health care healthcare self model include factor intervention management medical,1,0.0004085222,0.45157534,0.0004136943,0.0005177098,0.0005521116,0.37990296,0.16483405,0.00061566633,0.0004789701,0.0007010061,Family Medicine
CMP_73,email,C0072,treatment use respiratory cancer type therapy clinical need care obesity,2,0.0014466349,0.0021116196,0.5924972,0.0018332837,0.23970777,0.15390961,0.002135215,0.0021801621,0.0016961007,0.002482357,General Practice
CMP_74,email,C0073,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0016236475,0.0023700013,0.113461725,0.0020576073,0.081112005,0.78984183,0.002396483,0.00244693,0.0019036385,0.0027861092,General Practice
CMP_75,email,C0074,thyroid disorder drug infection role include relate adverse function gut,4,0.00032516883,0.00047464148,0.00032928563,0.0004120782,0.7277586,0.268791,0.00047994504,0.00049004826,0.00038124277,0.0005579737,Internal Medicine
CMP_76,in-person,C0075,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0012243787,0.0017871972,0.00123988,0.0015516242,0.0016547294,0.9853533,0.0018071674,0.0018452087,0.0014355174,0.0021009766,General Practice
CMP_77,social-event,C0076,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.00042597565,0.0006217868,0.0004313687,0.00053982815,0.00057569967,0.00072428834,0.0006287347,0.99482197,0.0004994333,0.0007309543,General Practice
CMP_78,email,C0077,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0005418391,0.0007909101,0.000548699,0.0006866589,0.00073228736,0.99351823,0.00079974777,0.0008165828,0.00063527684,0.00092977233,General Practice
CMP_79,webinar,C0078,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.00046042746,0.0006720753,0.0004662567,0.000583488,0.00062226073,0.33741656,0.00067958515,0.0006938906,0.0005398262,0.6578656,Cardiology
CMP_80,email,C0079,treatment use respiratory cancer type therapy clinical need care obesity,2,0.00040435404,0.00059022626,0.9948849,0.0005124276,0.0005464784,0.0006875276,0.00059682137,0.00060938473,0.00047408312,0.0006938523,General Practice
CMP_81,webinar,C0080,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.00089458114,0.18180774,0.00090590696,0.00113368,0.0012090129,0.3078035,0.056187857,0.0013481852,0.0010488478,0.44766068,Cardiology
CMP_82,webinar,C0081,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.00041274918,0.11709103,0.0004179748,0.0005230666,0.00055782427,0.00070179923,0.08923669,0.00062203663,0.00048392598,0.7899529,Cardiology
CMP_83,email,C0082,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.00028150962,0.00041091305,0.00028507365,0.00035674998,0.00038045598,0.00047865158,0.016492605,0.00042425113,0.00033005473,0.98055977,Cardiology
CMP_84,rep_visit,C0083,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.00083810533,0.0012233631,0.0008487161,0.0010621096,0.2482144,0.0014250353,0.0012370333,0.74273044,0.000982633,0.0014381518,General Practice
CMP_85,webinar,C0084,thyroid disorder drug infection role include relate adverse function gut,4,0.0009827893,0.001434555,0.0009952319,0.001245464,0.87001866,0.001671041,0.119332455,0.0014811199,0.001152267,0.0016864218,Internal Medicine
CMP_86,email,C0085,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.0010338331,0.0015090624,0.0010469219,0.0013101505,0.0013972098,0.0017578308,0.0015259252,0.98743296,0.0012121132,0.0017740104,General Practice
CMP_87,social-event,C0086,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0022712194,0.3193361,0.002299974,0.0028782587,0.0030695186,0.52838516,0.0033522907,0.13184729,0.002662881,0.003897307,General Practice
CMP_88,email,C0087,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.000440088,0.0006423863,0.00044565974,0.0005577124,0.0005947723,0.0007482834,0.026102584,0.0006632379,0.00051597925,0.9692893,Cardiology
CMP_89,email,C0088,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0027399405,0.16109279,0.0027746293,0.003472257,0.0037029881,0.44220486,0.36846036,0.007638108,0.0032124312,0.0047016195,General Practice
CMP_90,rep_visit,C0089,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.2969457,0.0033151158,0.002299883,0.0028781446,0.003069397,0.6781569,0.0033521594,0.003422722,0.0026627758,0.0038971591,General Practice
CMP_91,webinar,C0090,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.0002961725,0.00043231618,0.0002999222,0.0003753319,0.16588128,0.061704636,0.00043714695,0.00044634903,0.00034724615,0.76977956,Cardiology
CMP_92,webinar,C0091,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0015011573,0.0021912048,0.0015201627,0.0019023785,0.0020287912,0.9820424,0.0022156897,0.0022623297,0.0017600253,0.0025759148,General Practice
CMP_93,email,C0092,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.006088706,0.008887544,0.0061657922,0.0077160634,0.008228796,0.92716354,0.008986855,0.009176037,0.0071386774,0.0104479445,General Practice
CMP_94,webinar,C0093,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.00033055773,0.00048250752,0.00033474274,0.0004189074,0.00044674377,0.00056204834,0.00048789912,0.00049816945,0.00038756095,0.99605083,Cardiology
CMP_95,in-person,C0094,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.00029183185,0.00042598025,0.07591674,0.0003698311,0.00039440635,0.5560067,0.36531174,0.00043980734,0.00034215697,0.0005007701,General Practice
CMP_96,email,C0095,risk age factor high year disease prevalence associate cardiovascular group,6,0.0037791145,0.005516286,0.0038269598,0.004789176,0.0051074154,0.006425655,0.3540477,0.0056953407,0.2824079,0.32840446,General Practice
CMP_97,email,C0096,health care healthcare self model include factor intervention management medical,1,0.0008945695,0.3829696,0.2121864,0.0011336652,0.0012089972,0.065165736,0.0013203735,0.0013481675,0.0010488341,0.33272368,Family Medicine
CMP_98,email,C0097,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.00087489083,0.001277058,0.00088596734,0.001108727,0.31469345,0.21158727,0.0012913279,0.0013185107,0.001025762,0.46593705,Cardiology
CMP_99,rep_visit,C0098,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0005648928,0.045581296,0.0005720446,0.00071587425,0.029526439,0.7274471,0.00083377457,0.19312689,0.00066230603,0.0009693302,General Practice
CMP_100,webinar,C0099,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.00041707102,0.2272684,0.00042235135,0.00052854355,0.0005636652,0.6582692,0.00061559165,0.0006285501,0.00048899313,0.11079764,General Practice
CMP_101,email,C0100,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.00047695893,0.0006962059,0.00048299745,0.00060443796,0.00064460275,0.00081097515,0.00070398534,0.0007188044,0.0005592084,0.9943018,Cardiology
CMP_102,in-person,C0101,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0016235176,0.0023698113,0.001644072,0.0020574427,0.0021941597,0.59666723,0.30408737,0.0024467343,0.0019034861,0.08500616,General Practice
CMP_103,rep_visit,C0102,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.00035094866,0.00051227177,0.00035539182,0.00044474832,0.0004743018,0.27537215,0.13154267,0.54565513,0.0004114682,0.044880945,General Practice
CMP_104,webinar,C0103,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.025799971,0.037659615,0.02612661,0.032695647,0.034868266,0.04386767,0.03808042,0.6863813,0.030249063,0.044271424,General Practice
CMP_105,rep_visit,C0104,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.0005899361,0.00086111604,0.00059740496,0.00074761105,0.0007972897,0.0010030698,0.00087073835,0.0008890675,0.000691668,0.99295205,Cardiology
CMP_106,webinar,C0105,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.0013487051,0.0019686737,0.0013657804,0.0017091797,0.0018227545,0.0022932093,0.0019906722,0.0020325761,0.0015812834,0.9838872,Cardiology
CMP_107,in-person,C0106,treatment use respiratory cancer type therapy clinical need care obesity,2,0.0011534924,0.0016837261,0.4941795,0.0014617917,0.0015589276,0.49318987,0.0017025406,0.0017383796,0.0013524072,0.0019793443,General Practice
CMP_108,rep_visit,C0107,treatment use respiratory cancer type therapy clinical need care obesity,2,0.00034190563,0.00049907184,0.99567485,0.00043328834,0.0004620803,0.0005813458,0.00050464843,0.0005152714,0.00040086577,0.00058669446,General Practice
CMP_109,webinar,C0108,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.13074774,0.0012770921,0.0008859911,0.0011087566,0.0011824333,0.121119246,0.0012913626,0.0013185459,0.0010257894,0.74004304,Cardiology
CMP_110,rep_visit,C0109,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.00048274567,0.0007046528,0.00048885745,0.0006117713,0.0006524235,0.0008208151,0.2060639,0.41852584,0.000565993,0.37108302,General Practice
CMP_111,email,C0110,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.001623491,0.0023697726,0.0016440452,0.0020574091,0.0021941233,0.002760426,0.0023962527,0.0024466938,0.001903455,0.98060435,Cardiology
CMP_112,in-person,C0111,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.0005345423,0.0007802591,0.0005413098,0.0006774119,0.0007224258,0.0009088842,0.0007889777,0.99350226,0.00062672177,0.00091725076,General Practice
CMP_113,webinar,C0112,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.025799971,0.037659615,0.02612661,0.032695647,0.034868266,0.04386767,0.03808042,0.6863813,0.030249063,0.044271424,General Practice
CMP_114,email,C0113,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.29270414,0.001843908,0.0012792232,0.0016008595,0.0017072364,0.002147884,0.0018645123,0.0019037612,0.0014810687,0.6934674,Cardiology
CMP_115,email,C0114,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.00044007355,0.00064236514,0.0004456451,0.00055769406,0.0005947527,0.9947356,0.00064954296,0.000663216,0.0005159623,0.00075514556,General Practice
CMP_116,email,C0115,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.0020387706,0.0029759463,0.0020645824,0.0025836823,0.3984214,0.003466532,0.0030092003,0.0030725445,0.0023903477,0.579977,Cardiology
CMP_117,in-person,C0116,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.025799971,0.037659615,0.02612661,0.032695647,0.034868266,0.04386767,0.03808042,0.6863813,0.030249063,0.044271424,General Practice
CMP_118,webinar,C0117,health care healthcare self model include factor intervention management medical,1,0.0052816826,0.93554676,0.005348551,0.0066933422,0.007138114,0.00898047,0.0077956985,0.007959799,0.0061924853,0.0090631265,Family Medicine
CMP_119,social-event,C0118,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.001767468,0.0025799323,0.0017898451,0.0022398676,0.0023887062,0.0030052273,0.0026087642,0.002663676,0.0020722602,0.9788843,Cardiology
CMP_120,rep_visit,C0119,thyroid disorder woman hormone disease hypothyroidism association pregnancy tsh level,0,0.995127,0.0005617168,0.00038969473,0.00048767604,0.000520082,0.0006543149,0.0005679935,0.0005799499,0.00045118367,0.0006603398,Endocrinology
CMP_121,rep_visit,C0120,treatment use respiratory cancer type therapy clinical need care obesity,2,0.001348707,0.0019686767,0.5522208,0.0017091822,0.0018227572,0.0022932142,0.0019906745,0.0020325794,0.0015812856,0.4330321,General Practice
CMP_122,email,C0121,thyroid disorder drug infection role include relate adverse function gut,4,0.0017675082,0.0025799912,0.0017898857,0.0022399183,0.97823954,0.0030053032,0.0026088203,0.0026637367,0.0020723073,0.0030329719,Internal Medicine
CMP_123,email,C0122,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.0016923606,0.0024702998,0.0017137867,0.0021446857,0.0022872,0.002877525,0.002497903,0.979428,0.001984201,0.0029040112,General Practice
CMP_124,in-person,C0123,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.22835512,0.0017872215,0.0012398965,0.0015516449,0.0016547516,0.002081846,0.20948397,0.0018452337,0.0014355367,0.55056477,Cardiology
CMP_125,email,C0124,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.00042598063,0.00062179414,0.00043137374,0.00053983444,0.00057570636,0.5594049,0.00062874204,0.30531505,0.00049943913,0.13155718,General Practice
CMP_126,rep_visit,C0125,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.002739642,0.0039989916,0.0027743273,0.0034718788,0.29005957,0.0046582147,0.004043679,0.6803405,0.0032120813,0.0047011003,General Practice
CMP_127,in-person,C0126,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.0015011337,0.00219117,0.0015201387,0.0019023486,0.2948847,0.0025523824,0.0022156546,0.0022622945,0.08628523,0.60468495,Cardiology
CMP_128,email,C0127,risk age factor high year disease prevalence associate cardiovascular group,6,0.0020388681,0.11976781,0.0020646811,0.002583806,0.0027554992,0.0034666893,0.8583609,0.003072691,0.002390462,0.0034986038,General Practice
CMP_129,in-person,C0128,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.0020387848,0.0029759668,0.0020645969,0.0025837005,0.44517818,0.0034665538,0.003009221,0.53279424,0.0023903644,0.0034984606,General Practice
CMP_130,in-person,C0129,treatment use respiratory cancer type therapy clinical need care obesity,2,0.0018495535,0.2356335,0.537757,0.0023438924,0.20841177,0.0031447995,0.0027299176,0.0027873833,0.002168501,0.0031737557,General Practice
CMP_131,in-person,C0130,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.0016925278,0.002470544,0.001713956,0.0021448976,0.0022874258,0.0028778121,0.00249815,0.25254515,0.0019843967,0.72978514,Cardiology
CMP_132,social-event,C0131,risk age factor high year disease prevalence associate cardiovascular group,6,0.0017674346,0.37554872,0.0017898112,0.002239825,0.002388661,0.003005174,0.6054917,0.002663625,0.002072221,0.0030328329,General Practice
CMP_133,in-person,C0132,thyroid disorder woman hormone disease hypothyroidism association pregnancy tsh level,0,0.5432336,0.43132204,0.0022999325,0.0028782065,0.0030694632,0.003861697,0.0033522313,0.0034227958,0.002662833,0.003897243,Endocrinology
CMP_134,rep_visit,C0133,thyroid disorder woman hormone disease hypothyroidism association pregnancy tsh level,0,0.49364194,0.0031364295,0.0021759188,0.002723012,0.0029039558,0.00365347,0.0031714768,0.0032382372,0.0025192515,0.48283625,Endocrinology
CMP_135,social-event,C0134,risk age factor high year disease prevalence associate cardiovascular group,6,0.00034488208,0.3232789,0.00034924847,0.0004370603,0.0004661029,0.00058640516,0.5721232,0.00051975716,0.0004043555,0.101490006,General Practice
CMP_136,rep_visit,C0135,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.00040850264,0.0005962819,0.00041367448,0.0005176851,0.00055208517,0.7003036,0.00060294475,0.2954253,0.00047894716,0.00070097187,General Practice
CMP_137,in-person,C0136,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.00024365187,0.000355653,0.0002467366,0.00030877383,0.0003292918,0.52686906,0.0003596271,0.31325716,0.00028566856,0.1577444,General Practice
CMP_138,email,C0137,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.00020171172,0.00029443394,0.00020426548,0.00025562415,0.00027261034,0.00034297112,0.00029772418,0.0003039911,0.00023649602,0.9975902,Cardiology
CMP_139,email,C0138,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.00024216952,0.0003534893,0.0002452355,0.0003068953,0.00032728846,0.0004117616,0.00035743922,0.32459927,0.0002839306,0.67287254,Cardiology
CMP_140,rep_visit,C0139,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0003963196,0.0005784985,0.0004013372,0.0005022458,0.0005356199,0.6750522,0.00058496266,0.32080403,0.00046466317,0.00068006525,General Practice
CMP_141,rep_visit,C0140,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.00055702426,0.041841924,0.0005640764,0.031199694,0.08385839,0.0009471118,0.0008221609,0.0008394674,0.00065308064,0.8387171,Cardiology
CMP_142,email,C0141,risk age factor high year disease prevalence associate cardiovascular group,6,0.00037053126,0.0005408559,0.00037522236,0.00046956487,0.0005007674,0.00063001586,0.99548435,0.000558412,0.00043442775,0.0006358151,General Practice
CMP_143,in-person,C0142,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.0003885966,0.0005672255,0.00039351644,0.00049245864,0.11716933,0.0006607321,0.00057356374,0.6438206,0.00045560842,0.23547839,General Practice
CMP_144,rep_visit,C0143,risk age factor high year disease prevalence associate cardiovascular group,6,0.0002664644,0.00038895197,0.00026983797,0.0003376836,0.00036012265,0.00045307106,0.9967527,0.00040157733,0.00031241504,0.00045724062,General Practice
CMP_145,webinar,C0144,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.00032785098,0.0004785566,0.00033200174,0.00041547726,0.00044308565,0.00055744656,0.00048390412,0.0004940903,0.115711115,0.88075644,Cardiology
CMP_146,email,C0145,risk age factor high year disease prevalence associate cardiovascular group,6,0.00036048438,0.0005261908,0.14130731,0.00045683273,0.0004871892,0.00061293395,0.655529,0.1996788,0.00042264833,0.0006185753,General Practice
CMP_147,email,C0146,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.0003029169,0.00044216076,0.00030675196,0.00038387888,0.00040938758,0.0005150504,0.00044710157,0.00045651308,0.00035515358,0.99638104,Cardiology
CMP_148,webinar,C0147,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.00029618095,0.00043232855,0.00029993075,0.00037534258,0.00040028407,0.37627664,0.32793793,0.00044636175,0.00034725605,0.29318774,General Practice
CMP_149,social-event,C0148,risk age factor high year disease prevalence associate cardiovascular group,6,0.0019395765,0.0028311547,0.0019641325,0.002457976,0.3185139,0.003297873,0.39282534,0.0029230532,0.002274048,0.2709729,General Practice
CMP_150,webinar,C0149,health care healthcare self model include factor intervention management medical,1,0.00039633148,0.88332725,0.0004013492,0.0005022608,0.1123719,0.0006738842,0.00058498036,0.0005972942,0.0004646771,0.00068008696,Family Medicine
CMP_151,rep_visit,C0150,risk age factor high year disease prevalence associate cardiovascular group,6,0.00043057938,0.0006285069,0.00043603074,0.00054566236,0.00058192154,0.00073211547,0.9947526,0.00064890797,0.0005048309,0.0007388554,General Practice
CMP_152,rep_visit,C0151,risk age factor high year disease prevalence associate cardiovascular group,6,0.00035094572,0.00051226735,0.00035538885,0.0004447446,0.00047429782,0.0005967146,0.55333436,0.0005288953,0.00041146477,0.44299096,General Practice
CMP_153,social-event,C0152,risk age factor high year disease prevalence associate cardiovascular group,6,0.00034787026,0.00050777826,0.00035227448,0.00044084716,0.00047014141,0.0005914853,0.99576056,0.00052426045,0.00040785898,0.0005969292,General Practice
CMP_154,rep_visit,C0153,risk age factor high year disease prevalence associate cardiovascular group,6,0.0003885841,0.00056720723,0.00039350375,0.00049244275,0.0005251655,0.0006607103,0.7467993,0.0005856186,0.00045559372,0.24913184,General Practice
CMP_155,rep_visit,C0154,risk age factor high year disease prevalence associate cardiovascular group,6,0.0003885756,0.0005671948,0.00039349517,0.000492432,0.00052515406,0.00066069624,0.3579192,0.2976517,0.00045558377,0.340946,General Practice
CMP_156,social-event,C0155,risk age factor high year disease prevalence associate cardiovascular group,6,0.00032253485,0.00047079675,0.20772927,0.00040874025,0.000435901,0.00054840796,0.78866667,0.0004860786,0.0003781546,0.0005534552,General Practice
CMP_157,email,C0156,thyroid disorder drug infection role include relate adverse function gut,4,0.20331882,0.00028025912,0.00019443159,0.2560975,0.28549445,0.25348723,0.00028339078,0.00028935625,0.00022511046,0.0003294647,Internal Medicine
CMP_158,email,C0157,risk age factor high year disease prevalence associate cardiovascular group,6,0.00035093978,0.0005122587,0.00035538286,0.0004447371,0.00047428982,0.00059670437,0.59111905,0.0005288864,0.00041145782,0.4052063,General Practice
CMP_159,email,C0158,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.00021593152,0.108341865,0.00021866531,0.00027364455,0.00029182818,0.00036714945,0.22249109,0.00032542122,0.00025316796,0.6672212,Cardiology
CMP_160,email,C0159,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.00039241186,0.0005727945,0.00039738,0.0004972936,0.00053033873,0.0006672192,0.00057919504,0.08558004,0.0004600816,0.91032326,Cardiology
CMP_161,rep_visit,C0160,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.00054181984,0.000790882,0.00054867956,0.00068663456,0.27604297,0.37436533,0.1339403,0.2115184,0.0006352543,0.0009297386,General Practice
CMP_162,in-person,C0161,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.00045517832,0.00066441327,0.00046094108,0.00057683594,0.33413985,0.00077394134,0.0006718375,0.00068597996,0.0005336718,0.6610374,Cardiology
CMP_163,webinar,C0162,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.0387852,0.00045963953,0.00031887795,0.00039905374,0.00042557082,0.00053541065,0.00046477566,0.43715692,0.00036919292,0.5210854,Cardiology
CMP_164,rep_visit,C0163,risk age factor high year disease prevalence associate cardiovascular group,6,0.01794116,0.0007046503,0.00048885576,0.0006117692,0.00065242127,0.00082081265,0.76554847,0.2118375,0.0005659911,0.0008283675,General Practice
CMP_165,rep_visit,C0164,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.0005729628,0.00083634054,0.00058021676,0.0007261012,0.00077435054,0.0009742125,0.0008456859,0.99303526,0.00067176775,0.0009831769,General Practice
CMP_166,email,C0165,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.0031766254,0.0046368474,0.003216843,0.6819785,0.0042931614,0.0054012393,0.0046886606,0.28343275,0.0037244207,0.0054509486,Family Medicine
CMP_167,email,C0166,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.00040436786,0.00059024646,0.00040948737,0.0005124452,0.00054649706,0.9951627,0.000596842,0.00060940575,0.00047409936,0.00069387635,General Practice
CMP_168,email,C0167,thyroid disorder drug infection role include relate adverse function gut,4,0.00044009587,0.0006423979,0.00044566768,0.00055772235,0.5939256,0.0007482973,0.00064957596,0.4013195,0.0005159885,0.0007551846,Internal Medicine
CMP_169,in-person,C0168,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.00037052954,0.00054085354,0.20181553,0.2768686,0.0005007651,0.0006300133,0.27087364,0.24732983,0.00043442575,0.00063581206,Family Medicine
CMP_170,webinar,C0169,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.00036046322,0.00052615977,0.00036502685,0.0004568059,0.00048716058,0.0006128962,0.0005320392,0.00054323877,0.0004226235,0.99569356,Cardiology
CMP_171,in-person,C0170,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.0002336474,0.00034104974,0.00023660548,0.00029609542,0.00031577094,0.0003972715,0.00034486066,0.00035212006,0.00027393887,0.9972086,Cardiology
CMP_172,social-event,C0171,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.00048866717,0.0007132961,0.0004948539,0.0006192755,0.20289962,0.3866256,0.00072126667,0.406026,0.0005729357,0.0008385304,General Practice
CMP_173,in-person,C0172,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.0003572296,0.0005214398,0.00036175232,0.00045270802,0.00048279043,0.00060739816,0.27525192,0.40176082,0.0004188323,0.31978512,General Practice
CMP_174,in-person,C0173,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.00039633195,0.00057851657,0.0004013497,0.00050226145,0.11175412,0.5440841,0.14748645,0.048254468,0.00046467767,0.14607775,General Practice
CMP_175,in-person,C0174,risk age factor high year disease prevalence associate cardiovascular group,6,0.00047697936,0.00069623574,0.00048301814,0.0006044638,0.0006446304,0.0008110091,0.89216214,0.0007188353,0.0005592324,0.10284344,General Practice
CMP_176,social-event,C0175,risk age factor high year disease prevalence associate cardiovascular group,6,0.0025633655,0.0037416855,0.002595819,0.003248488,0.0034643498,0.0043584947,0.9687606,0.0038631393,0.0030054068,0.0043986184,General Practice
CMP_177,rep_visit,C0176,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.00044009506,0.00064239657,0.00044566687,0.0005577213,0.20725803,0.41198483,0.0006495749,0.3767505,0.0005159875,0.0007551845,General Practice
CMP_178,in-person,C0177,risk age factor high year disease prevalence associate cardiovascular group,6,0.002739796,0.0039992165,0.002774483,0.003472074,0.003702793,0.32241377,0.64885515,0.0041290303,0.0032122617,0.0047013657,General Practice
CMP_179,social-event,C0178,risk age factor high year disease prevalence associate cardiovascular group,6,0.00039632,0.0005784992,0.32493597,0.0005022463,0.0005356205,0.000673864,0.6706355,0.00059727696,0.00046466367,0.0006800676,General Practice
CMP_180,webinar,C0179,treatment use respiratory cancer type therapy clinical need care obesity,2,0.025800189,0.037659932,0.673623,0.032695927,0.034868564,0.04386808,0.03808075,0.03888235,0.03024932,0.0442718,General Practice
CMP_181,email,C0180,treatment use respiratory cancer type therapy clinical need care obesity,2,0.0013959511,0.0020376376,0.98234093,0.0017690535,0.0018866069,0.0023735403,0.0020604064,0.0021037804,0.0016366768,0.0023953854,General Practice
CMP_182,rep_visit,C0181,risk age factor high year disease prevalence associate cardiovascular group,6,0.002271209,0.003315231,0.0022999635,0.0028782454,0.28935012,0.0038617507,0.68604046,0.0034228435,0.002662869,0.0038972914,General Practice
CMP_183,social-event,C0182,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.0012632959,0.0018440037,0.0012792898,0.0016009428,0.35971224,0.0021479847,0.0018646091,0.00190386,0.0014811457,0.6269026,Cardiology
CMP_184,social-event,C0183,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.0015598768,0.002276916,0.0015796256,0.0019767922,0.00210815,0.0026522717,0.0023023586,0.002350824,0.0018288707,0.9813643,Cardiology
CMP_185,in-person,C0184,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.0016235827,0.002369906,0.001644138,0.002057525,0.0021942477,0.0027605868,0.35105172,0.24151555,0.0019035623,0.39287916,Cardiology
CMP_186,social-event,C0185,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0005345669,0.27451813,0.00054133474,0.000677443,0.00072245905,0.57296264,0.00078901416,0.0008056228,0.0006267506,0.14782202,General Practice
CMP_187,in-person,C0186,risk age factor high year disease prevalence associate cardiovascular group,6,0.14048393,0.003515657,0.0024390107,0.0030522533,0.0032550748,0.004095209,0.83257234,0.0036297732,0.002823856,0.004132909,General Practice
CMP_188,social-event,C0187,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.0027397217,0.003999109,0.0027744079,0.25384402,0.003702692,0.004658356,0.0040437956,0.0041289176,0.0854024,0.63470656,Cardiology
CMP_189,rep_visit,C0188,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.0034519031,0.0050386637,0.0034956057,0.004374509,0.0046651945,0.005869297,0.43087965,0.0052022166,0.0040471684,0.5329758,Cardiology
CMP_190,webinar,C0189,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.001560001,0.0022770974,0.14845364,0.0019769499,0.0021083178,0.0026524744,0.0023025426,0.0023510118,0.0018290165,0.834489,Cardiology
CMP_191,social-event,C0190,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.002038778,0.002975958,0.00206459,0.0025836919,0.002755378,0.68187416,0.003009211,0.0030725559,0.0023903565,0.29723537,General Practice
CMP_192,email,C0191,risk age factor high year disease prevalence associate cardiovascular group,6,0.002148694,0.0031363985,0.0021758974,0.0027229853,0.0029039276,0.003653434,0.9738142,0.0032382049,0.0025192269,0.0036870616,General Practice
CMP_193,webinar,C0192,risk age factor high year disease prevalence associate cardiovascular group,6,0.0025633231,0.0037416231,0.0025957762,0.0032484345,0.2444943,0.004358422,0.7277311,0.0038630746,0.0030053572,0.0043985425,General Practice
CMP_194,email,C0193,risk age factor high year disease prevalence associate cardiovascular group,6,0.0009828295,0.0014346137,0.0009952727,0.001245515,0.0013282793,0.10143692,0.6592448,0.001481181,0.0011523141,0.2306983,General Practice
CMP_195,email,C0194,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.02579997,0.03765961,0.026126608,0.032695647,0.034868266,0.043867666,0.03808042,0.68638134,0.030249061,0.04427142,General Practice
CMP_196,rep_visit,C0195,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.025799971,0.037659615,0.02612661,0.032695647,0.034868266,0.04386767,0.03808042,0.6863813,0.030249063,0.044271424,General Practice
CMP_197,rep_visit,C0196,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.00048867054,0.00071330124,0.0004948574,0.08166959,0.0006604309,0.79493207,0.00072127173,0.0007364547,0.0005729397,0.11901038,General Practice
CMP_198,webinar,C0197,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0034514682,0.005038028,0.0034951654,0.004373958,0.004664607,0.9587117,0.0050943233,0.00520156,0.0040466585,0.0059225555,General Practice
CMP_199,email,C0198,risk age factor high year disease prevalence associate cardiovascular group,6,0.0011878937,0.0017339409,0.0012029329,0.0015053875,0.0016054204,0.44588727,0.5416559,0.0017902242,0.0013927408,0.0020383715,General Practice
CMP_200,rep_visit,C0199,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.0027396043,0.0039989366,0.0027742889,0.003471831,0.0037025337,0.0046581645,0.004043622,0.004128742,0.003212037,0.96727026,Cardiology
CMP_201,email,C0200,treatment use respiratory cancer type therapy clinical need care obesity,2,0.0008945483,0.0013057515,0.5535741,0.0011336383,0.0012089685,0.0015210042,0.0013203422,0.4364578,0.0010488093,0.0015350038,General Practice
CMP_202,in-person,C0201,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.00032783675,0.00047853577,0.00033198734,0.00041545922,0.00044306638,0.0005574214,0.00048388293,0.9960149,0.00038437077,0.000562552,General Practice
CMP_203,in-person,C0202,treatment use respiratory cancer type therapy clinical need care obesity,2,0.000381148,0.000556353,0.51430273,0.00048301922,0.0005151158,0.00064806774,0.0005625697,0.48145008,0.00044687535,0.00065403176,General Practice
CMP_204,in-person,C0203,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.0052817743,0.0077096834,0.0053486438,0.93452936,0.007138238,0.008980613,0.007795831,0.00795994,0.006192593,0.009063289,Family Medicine
CMP_205,webinar,C0204,treatment use respiratory cancer type therapy clinical need care obesity,2,0.00035722877,0.00052143866,0.8036812,0.00045270694,0.00048278927,0.0006073972,0.00052726525,0.0005383642,0.1922186,0.00061298785,General Practice
CMP_206,rep_visit,C0205,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.00029838257,0.0004355423,0.00030216025,0.0017760108,0.00040325953,0.00050734123,0.000440409,0.9949751,0.00034983733,0.000512011,General Practice
CMP_207,email,C0206,thyroid disorder drug infection role include relate adverse function gut,4,0.000589944,0.00086112786,0.3879258,0.0007476211,0.6054086,0.0010030852,0.0008707502,0.00088907965,0.00069167727,0.0010123203,Internal Medicine
CMP_208,social-event,C0207,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.000804323,0.0011740518,0.21065101,0.0010192982,0.0010870304,0.0013675933,0.22974122,0.001212161,0.000943025,0.5520003,Cardiology
CMP_209,in-person,C0208,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.16787146,0.1550881,0.0017139912,0.29685396,0.0022874726,0.0028778706,0.0024982006,0.36592013,0.0019844375,0.0029043583,General Practice
CMP_210,email,C0209,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.000465793,0.0006799072,0.00047169015,0.0005902877,0.0006295121,0.00079198857,0.00068750454,0.994338,0.00054611696,0.00079927815,General Practice
CMP_211,webinar,C0210,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.0004886431,0.0007132611,0.0004948296,0.00061924505,0.00066039374,0.0008308408,0.00072123104,0.9940602,0.0005729075,0.00083848793,General Practice
CMP_212,webinar,C0211,risk age factor high year disease prevalence associate cardiovascular group,6,0.1130232,0.000572796,0.000397381,0.0004972949,0.00053034007,0.00066722033,0.54432213,0.00059138896,0.00046008275,0.33893818,General Practice
CMP_213,webinar,C0212,thyroid disorder drug infection role include relate adverse function gut,4,0.00040851644,0.0005963021,0.00041368845,0.0005177025,0.42470917,0.00069460185,0.41535982,0.0006156577,0.0004789633,0.15620558,Internal Medicine
CMP_214,social-event,C0213,risk age factor high year disease prevalence associate cardiovascular group,6,0.17958282,0.00040520876,0.00028111623,0.00035179753,0.00037517442,0.00047200694,0.55941176,0.25831828,0.00032547282,0.00047635206,General Practice
CMP_215,social-event,C0214,thyroid disorder drug infection role include relate adverse function gut,4,0.29682553,0.00067993836,0.0004717117,0.0005903146,0.43134898,0.2673485,0.00068753597,0.00070200907,0.0005461419,0.0007993152,Internal Medicine
CMP_216,rep_visit,C0215,thyroid disorder drug infection role include relate adverse function gut,4,0.020791233,0.00080180744,0.0005562591,0.00069611985,0.41491863,0.11248148,0.0008107669,0.2687279,0.0006440299,0.17957172,Internal Medicine
CMP_217,social-event,C0216,risk age factor high year disease prevalence associate cardiovascular group,6,0.36844173,0.002369693,0.0016439902,0.0020573402,0.00219405,0.0027603344,0.6133971,0.002446614,0.0019033912,0.002785744,General Practice
CMP_218,webinar,C0217,health care healthcare self model include factor intervention management medical,1,0.2237505,0.77238584,0.00034923674,0.00043704564,0.00046608728,0.0005863844,0.0005090246,0.00051973964,0.00040434193,0.0005917817,Family Medicine
CMP_219,email,C0218,thyroid disorder drug infection role include relate adverse function gut,4,0.002408551,0.0035157066,0.0024390444,0.003052296,0.7926185,0.18182415,0.0035549935,0.0036298237,0.002823895,0.0041329684,Internal Medicine
CMP_220,webinar,C0219,health care healthcare self model include factor intervention management medical,1,0.23743077,0.6182821,0.14112812,0.00039284525,0.00041894976,0.0005270812,0.00045754458,0.000467176,0.00036344898,0.0005319318,Family Medicine
CMP_221,social-event,C0220,thyroid disorder woman hormone disease hypothyroidism association pregnancy tsh level,0,0.97123986,0.0033152525,0.0022999784,0.0028782643,0.0030695247,0.0038617675,0.003352297,0.0034228654,0.0026628864,0.0038973095,Endocrinology
CMP_222,rep_visit,C0221,risk age factor high year disease prevalence associate cardiovascular group,6,0.21214743,0.0022769787,0.0015796688,0.0019768465,0.0021082077,0.0026523375,0.31261533,0.17943758,0.0018289209,0.2833767,General Practice
CMP_223,social-event,C0222,risk age factor high year disease prevalence associate cardiovascular group,6,0.17288397,0.00096070004,0.0006664919,0.00083406863,0.0008894924,0.17041829,0.38776872,0.0009918838,0.00077165605,0.26381475,General Practice
CMP_224,in-person,C0223,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.0034516894,0.0050383518,0.0034953894,0.0043742387,0.004664906,0.005868923,0.005094651,0.95804197,0.0040469184,0.005922968,General Practice
CMP_225,in-person,C0224,thyroid disorder drug infection role include relate adverse function gut,4,0.0011210204,0.0016363276,0.0011352131,0.0014206407,0.84228855,0.0019060728,0.1455648,0.0016894417,0.0013143355,0.0019236183,Internal Medicine
CMP_226,email,C0225,thyroid disorder drug infection role include relate adverse function gut,4,0.00028555197,0.00041681365,0.0002891672,0.00036187278,0.9964845,0.0004855253,0.0004214712,0.0004303432,0.00033479417,0.00048999424,Internal Medicine
CMP_227,webinar,C0226,thyroid disorder drug infection role include relate adverse function gut,4,0.097709164,0.32332364,0.0011041871,0.0013818139,0.47805324,0.0018539842,0.09178128,0.0016432691,0.001278414,0.0018710468,Internal Medicine
CMP_228,rep_visit,C0227,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.0011535268,0.0016837765,0.2946481,0.0014618352,0.18638146,0.0019613495,0.0017025914,0.001738431,0.0013524474,0.5079165,Cardiology
CMP_229,in-person,C0228,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.0018494992,0.0026996708,0.0018729147,0.0023438234,0.0024995701,0.0031447064,0.0027298375,0.9775179,0.0021684372,0.0031736505,General Practice
CMP_230,rep_visit,C0229,health care healthcare self model include factor intervention management medical,1,0.40984654,0.46351966,0.00032142838,0.0004022454,0.00042897457,0.0005396932,0.00046849297,0.00047835472,0.00037214573,0.1236225,Family Medicine
CMP_231,email,C0230,thyroid disorder drug infection role include relate adverse function gut,4,0.276989,0.001636431,0.0011352845,0.11235674,0.4390141,0.0019061969,0.0016547163,0.0016895488,0.0013144183,0.16230358,Internal Medicine
CMP_232,social-event,C0231,thyroid disorder woman hormone disease hypothyroidism association pregnancy tsh level,0,0.83346283,0.0035155066,0.002438906,0.0030521224,0.0032549356,0.14013478,0.0035547896,0.0036296183,0.002823735,0.0041327327,Endocrinology
CMP_233,rep_visit,C0232,thyroid disorder drug infection role include relate adverse function gut,4,0.0010613148,0.0015491766,0.0010747516,0.0013449774,0.98693377,0.0018045561,0.0015664874,0.0015994627,0.0012443339,0.001821166,Internal Medicine
CMP_234,in-person,C0233,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.0071868044,0.010490413,0.007277793,0.009107656,0.009712857,0.012219769,0.010607635,0.010830928,0.008426137,0.91414,Cardiology
CMP_235,social-event,C0234,thyroid disorder drug infection role include relate adverse function gut,4,0.0004713175,0.0006879713,0.0004772846,0.0005972887,0.74554163,0.0008013835,0.0006956587,0.24936609,0.00055259414,0.0008087579,Internal Medicine
CMP_236,email,C0235,thyroid disorder woman hormone disease hypothyroidism association pregnancy tsh level,0,0.74968904,0.0050381874,0.21009943,0.0043740966,0.004664755,0.0058687264,0.005094492,0.0052017267,0.0040467866,0.005922768,Endocrinology
CMP_237,webinar,C0236,thyroid disorder drug infection role include relate adverse function gut,4,0.0010903438,0.0015915496,0.001104148,0.001381765,0.9865764,0.0018539137,0.0016093334,0.0016432105,0.0012783688,0.0018709787,Internal Medicine
CMP_238,webinar,C0237,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0018495097,0.002699687,0.35011435,0.0023438367,0.0024995843,0.6296337,0.0027298543,0.0027873174,0.0021684496,0.003173675,General Practice
CMP_239,social-event,C0238,thyroid disorder woman hormone disease hypothyroidism association pregnancy tsh level,0,0.99512696,0.00056172576,0.00038970096,0.00048768384,0.00052009034,0.0006543255,0.0005680026,0.00057995913,0.0004511909,0.00066034857,Endocrinology
CMP_240,in-person,C0239,thyroid disorder woman hormone disease hypothyroidism association pregnancy tsh level,0,0.73030466,0.0039990824,0.0027743897,0.0034719568,0.23870559,0.004658321,0.004043769,0.00412889,0.0032121534,0.004701201,Endocrinology
CMP_241,social-event,C0240,thyroid disorder drug infection role include relate adverse function gut,4,0.00033614103,0.0004906574,0.00034039674,0.000425983,0.99586165,0.0005715421,0.0004961399,0.00050658383,0.00039410708,0.00057680206,Internal Medicine
CMP_242,webinar,C0241,thyroid disorder drug infection role include relate adverse function gut,4,0.14088635,0.16337465,0.00058025384,0.0007261476,0.39151564,0.0009742733,0.00084573997,0.2994419,0.00067181065,0.0009832409,Internal Medicine
CMP_243,social-event,C0242,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.09393525,0.3351261,0.00029552775,0.00036983256,0.00039440792,0.0004962052,0.00043074187,0.00043980908,0.0003421583,0.56816995,Cardiology
CMP_244,email,C0243,risk age factor high year disease prevalence associate cardiovascular group,6,0.048177756,0.0010663669,0.0007397989,0.0009258072,0.000987327,0.0012421563,0.94364965,0.0011009808,0.0008565299,0.0012535921,General Practice
CMP_245,email,C0244,risk age factor high year disease prevalence associate cardiovascular group,6,0.0015011256,0.0021911582,0.0015201307,0.0019023385,0.0020287486,0.002552366,0.981706,0.002262282,0.0017599883,0.0025758608,General Practice
CMP_246,rep_visit,C0245,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.002739809,0.0039992365,0.002774496,0.32304433,0.0037028103,0.0046585076,0.004043925,0.6471232,0.003212277,0.0047013955,General Practice
CMP_247,social-event,C0246,thyroid disorder drug infection role include relate adverse function gut,4,0.0002646917,0.0003863644,0.00026804284,0.0003354371,0.6795681,0.00045005593,0.31756383,0.00039890557,0.00031033665,0.0004541991,Internal Medicine
CMP_248,email,C0247,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.025799971,0.037659615,0.02612661,0.032695647,0.034868266,0.04386767,0.03808042,0.6863813,0.030249063,0.044271424,General Practice
CMP_249,social-event,C0248,thyroid disorder woman hormone disease hypothyroidism association pregnancy tsh level,0,0.9776188,0.002579937,0.0017898486,0.0022398718,0.0023887113,0.0030052334,0.0026087658,0.0026636808,0.0020722642,0.0030328953,Endocrinology
CMP_250,in-person,C0249,thyroid disorder drug infection role include relate adverse function gut,4,0.2747596,0.002699775,0.0018729866,0.0023439133,0.5754801,0.0031448263,0.0027299428,0.13162659,0.0021685204,0.0031737757,Internal Medicine
CMP_251,webinar,C0250,risk age factor high year disease prevalence associate cardiovascular group,6,0.28984362,0.00043882217,0.0003044357,0.00038098026,0.00040629634,0.00051116163,0.70679325,0.000453066,0.00035247186,0.0005158669,General Practice
CMP_252,social-event,C0251,risk age factor high year disease prevalence associate cardiovascular group,6,0.028281137,0.00042598794,0.0002955319,0.00036983777,0.00039441342,0.0004962123,0.9684541,0.0004398153,0.00034216314,0.00050077867,General Practice
CMP_253,social-event,C0252,risk age factor high year disease prevalence associate cardiovascular group,6,0.0027396458,0.0039989976,0.002774331,0.0034718837,0.31170273,0.0046582287,0.6586122,0.0041288035,0.0032120857,0.0047011045,General Practice
CMP_254,email,C0253,risk age factor high year disease prevalence associate cardiovascular group,6,0.0052814763,0.007709249,0.0053483425,0.006693081,0.007137836,0.008980119,0.9356354,0.007959489,0.006192244,0.009062763,General Practice
CMP_255,email,C0254,risk age factor high year disease prevalence associate cardiovascular group,6,0.0020388484,0.0029760608,0.38617557,0.0025837808,0.0027554727,0.00346666,0.5910419,0.0030726627,0.002390439,0.003498575,General Practice
CMP_256,rep_visit,C0255,thyroid disorder woman hormone disease hypothyroidism association pregnancy tsh level,0,0.993576,0.00074050593,0.00051373086,0.00064289867,0.00068561925,0.00086257793,0.00074878044,0.00076454243,0.00059479114,0.0008705174,Endocrinology
CMP_257,social-event,C0256,thyroid disorder woman hormone disease hypothyroidism association pregnancy tsh level,0,0.47119215,0.17188378,0.00044081645,0.00055165135,0.0005883085,0.00074015144,0.00064250524,0.3527033,0.00051037176,0.0007469645,Endocrinology
CMP_258,social-event,C0257,thyroid disorder woman hormone disease hypothyroidism association pregnancy tsh level,0,0.8614949,0.0037416162,0.002595771,0.0032484285,0.0034642857,0.004358411,0.0037834249,0.0038630664,0.10905159,0.0043985257,Endocrinology
CMP_259,email,C0258,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.0018495043,0.0026996788,0.0018729198,0.00234383,0.0024995771,0.0031447168,0.0027298452,0.002787309,0.0021684433,0.9779042,Cardiology
CMP_260,in-person,C0259,thyroid disorder woman hormone disease hypothyroidism association pregnancy tsh level,0,0.7528732,0.17891416,0.0061657797,0.0077160476,0.008228778,0.010352614,0.008986837,0.009176008,0.0071386625,0.010447902,Endocrinology
CMP_261,in-person,C0260,thyroid disorder woman hormone disease hypothyroidism association pregnancy tsh level,0,0.9816816,0.0021116077,0.0014649418,0.0018332734,0.0019550943,0.0024597067,0.002135203,0.002180149,0.0016960913,0.0024823425,Endocrinology
CMP_262,email,C0261,health care healthcare self model include factor intervention management medical,1,0.15676305,0.5087366,0.00029337517,0.00036713877,0.00039153508,0.0004925902,0.33168224,0.00043660568,0.0003396661,0.00049712486,Family Medicine
CMP_263,rep_visit,C0262,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.0016925989,0.0024706477,0.0017140281,0.0021449877,0.002287522,0.09980351,0.36100373,0.46335176,0.06262683,0.0029044223,General Practice
CMP_264,rep_visit,C0263,thyroid disorder drug infection role include relate adverse function gut,4,0.048420038,0.0010471366,0.0007264579,0.0009091119,0.691091,0.2535942,0.0010588377,0.001081126,0.0008410839,0.0012309828,Internal Medicine
CMP_265,social-event,C0264,thyroid disorder drug infection role include relate adverse function gut,4,0.4148669,0.0019688352,0.0013658921,0.0017093197,0.41755256,0.002293396,0.15431446,0.0020327421,0.0015814129,0.002314509,Internal Medicine
CMP_266,email,C0265,risk age factor high year disease prevalence associate cardiovascular group,6,0.31877458,0.0003668789,0.0002545246,0.00031851995,0.00033968556,0.00042735925,0.6784136,0.00037878755,0.0002946854,0.0004312922,General Practice
CMP_267,rep_visit,C0266,health care healthcare self model include factor intervention management medical,1,0.39299133,0.5645226,0.0002662668,0.00033321453,0.00035535658,0.00044707386,0.0003880931,0.00039626248,0.00030828037,0.039991494,Family Medicine
CMP_268,email,C0267,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.16076651,0.0004109333,0.00028508768,0.00035676753,0.16321334,0.16757704,0.00041552508,0.38276052,0.00033007094,0.12388413,General Practice
CMP_269,email,C0268,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.32070848,0.0005459167,0.0003787333,0.00047395856,0.0005054531,0.00063591014,0.0005520168,0.6751192,0.0004384927,0.0006417634,General Practice
CMP_270,webinar,C0269,treatment use respiratory cancer type therapy clinical need care obesity,2,0.0016924224,0.00247039,0.97859055,0.002144764,0.0022872835,0.0028776298,0.0024979943,0.0025505782,0.0019842733,0.002904118,General Practice
CMP_271,rep_visit,C0270,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.031019654,0.0004259916,0.00029553444,0.00036984094,0.00039441683,0.0004962161,0.00043075165,0.00043981915,0.00034216608,0.96578556,Cardiology
CMP_272,email,C0271,thyroid disorder drug infection role include relate adverse function gut,4,0.00048272772,0.0007046265,0.0004888393,0.0006117486,0.99405694,0.0008207838,0.0007125,0.0007274985,0.000565972,0.00082833803,Internal Medicine
CMP_273,email,C0272,risk age factor high year disease prevalence associate cardiovascular group,6,0.001224404,0.0017872342,0.0012399055,0.0015516562,0.19178984,0.0020818613,0.5211835,0.27560508,0.0014355471,0.002101019,General Practice
CMP_274,rep_visit,C0273,thyroid disorder drug infection role include relate adverse function gut,4,0.0013487962,0.16433325,0.0013658726,0.0017092952,0.60233873,0.0022933607,0.0019908068,0.0020327137,0.0015813902,0.22100574,Internal Medicine
CMP_275,email,C0274,thyroid disorder woman hormone disease hypothyroidism association pregnancy tsh level,0,0.53721017,0.1190261,0.00042235036,0.0005285423,0.0005636639,0.0007091469,0.13073264,0.20960271,0.00048899197,0.0007156735,Endocrinology
CMP_276,email,C0275,thyroid disorder woman hormone disease hypothyroidism association pregnancy tsh level,0,0.9597789,0.0046363845,0.0032165227,0.0040252563,0.004292734,0.005400681,0.004688192,0.004786879,0.00372405,0.005450404,Endocrinology
CMP_277,social-event,C0276,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.0017675955,0.0025801186,0.0017899742,0.0022400294,0.0023888785,0.0030054573,0.0026089493,0.002663868,0.0020724097,0.97888273,Cardiology
CMP_278,webinar,C0277,thyroid disorder drug infection role include relate adverse function gut,4,0.00134875,0.0019687396,0.0013658258,0.0017092366,0.54656243,0.43912593,0.0019907383,0.0020326439,0.001581336,0.0023143936,Internal Medicine
CMP_279,social-event,C0278,thyroid disorder drug infection role include relate adverse function gut,4,0.00036374488,0.00053095,0.00036835007,0.0004609647,0.9955218,0.000618476,0.0005368829,0.0005481844,0.00042647112,0.0006241685,Internal Medicine
CMP_280,rep_visit,C0279,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.08873594,0.019354733,0.00040951636,0.00051248143,0.272498,0.0006875974,0.0005968841,0.6160368,0.0004741329,0.00069392496,General Practice
CMP_281,social-event,C0280,thyroid disorder drug infection role include relate adverse function gut,4,0.0017675305,0.0025800234,0.0017899083,0.0022399465,0.8475264,0.0030053386,0.1333218,0.0026637698,0.0020723334,0.0030329977,Internal Medicine
CMP_282,rep_visit,C0281,thyroid disorder drug infection role include relate adverse function gut,4,0.2270536,0.0035157602,0.0024390817,0.0030523425,0.39869565,0.35110164,0.003555045,0.0036298796,0.0028239384,0.004133028,Internal Medicine
CMP_283,social-event,C0282,health care healthcare self model include factor intervention management medical,1,0.00033056905,0.5774164,0.0003347542,0.00041892176,0.00044675905,0.0005620675,0.41903746,0.00049818656,0.00038757423,0.0005672413,Family Medicine
CMP_284,in-person,C0283,risk age factor high year disease prevalence associate cardiovascular group,6,0.18564409,0.002699722,0.00187295,0.0023438677,0.0024996174,0.0031447727,0.7936654,0.0027873546,0.0021684782,0.0031737126,General Practice
CMP_285,email,C0284,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.25870126,0.0006088148,0.00042236922,0.093790896,0.00056368904,0.0007091782,0.00061561767,0.073649935,0.0004890138,0.57044923,Cardiology
CMP_286,in-person,C0285,risk age factor high year disease prevalence associate cardiovascular group,6,0.26007298,0.00060247415,0.00041797032,0.000523061,0.0005578184,0.0007017919,0.4920339,0.0006220301,0.00048392083,0.24398407,General Practice
CMP_287,social-event,C0286,thyroid disorder drug infection role include relate adverse function gut,4,0.0029419144,0.0042942446,0.0029791603,0.0037282135,0.52419025,0.0050021433,0.443933,0.004433633,0.0034492346,0.0050481893,Internal Medicine
CMP_288,email,C0287,thyroid disorder woman hormone disease hypothyroidism association pregnancy tsh level,0,0.8523919,0.0005617622,0.00038972616,0.00048771538,0.000520124,0.0006543681,0.04777556,0.0005799968,0.00045122008,0.0961876,Endocrinology
CMP_289,rep_visit,C0288,thyroid disorder drug infection role include relate adverse function gut,4,0.35986456,0.0025799242,0.0017898394,0.0022398604,0.39996892,0.0030052182,0.0026087523,0.22283778,0.0020722535,0.0030328846,Internal Medicine
CMP_290,social-event,C0289,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.0005274669,0.00076993124,0.00053414487,0.0006684454,0.0007128636,0.00089685404,0.0007785345,0.99358827,0.00061842625,0.0009051092,General Practice
CMP_291,email,C0290,health care healthcare self model include factor intervention management medical,1,0.2508971,0.5471862,0.00041369325,0.00051770854,0.00055211026,0.0006946107,0.00060297217,0.124580294,0.0004789689,0.07407629,Family Medicine
CMP_292,social-event,C0291,thyroid disorder drug infection role include relate adverse function gut,4,0.14660835,0.0009767868,0.0006776523,0.00084803504,0.8458223,0.001137809,0.0009877015,0.001008493,0.00078457734,0.0011482812,Internal Medicine
CMP_293,in-person,C0292,thyroid disorder woman hormone disease hypothyroidism association pregnancy tsh level,0,0.5435577,0.00080182654,0.0005562723,0.0006961363,0.2624854,0.18867742,0.00081078603,0.0008278535,0.0006440451,0.00094260374,Endocrinology
CMP_294,social-event,C0293,risk age factor high year disease prevalence associate cardiovascular group,6,0.089416035,0.30899552,0.0003432922,0.00042960647,0.00045815378,0.0005764036,0.5982909,0.00051089283,0.0003974594,0.0005817101,General Practice
CMP_295,webinar,C0294,thyroid disorder woman hormone disease hypothyroidism association pregnancy tsh level,0,0.99284744,0.0008244847,0.00057199167,0.00071580807,0.0007633734,0.0009604001,0.00083369756,0.0008512471,0.0006622448,0.00096924487,Endocrinology
CMP_296,social-event,C0295,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.0022713805,0.0033154816,0.0023001372,0.002878463,0.0030697365,0.0038620355,0.44775888,0.003423101,0.00266307,0.5284577,Cardiology
CMP_297,social-event,C0296,thyroid disorder drug infection role include relate adverse function gut,4,0.25643674,0.001734014,0.0012029835,0.0015054508,0.6414726,0.09067333,0.0017533903,0.0017902992,0.0013927993,0.002038459,Internal Medicine
CMP_298,email,C0297,thyroid disorder woman hormone disease hypothyroidism association pregnancy tsh level,0,0.58601856,0.008887436,0.006165717,0.0077159693,0.008228694,0.3472345,0.008986744,0.009175919,0.00713859,0.010447831,Endocrinology
CMP_299,social-event,C0298,thyroid disorder drug infection role include relate adverse function gut,4,0.0005730021,0.000836398,0.17383614,0.00072615105,0.4519205,0.00097427884,0.0008457439,0.1791712,0.0006718138,0.19044475,Internal Medicine
CMP_300,webinar,C0299,treatment use respiratory cancer type therapy clinical need care obesity,2,0.0018496261,0.0026998578,0.5151151,0.0023439843,0.0024997415,0.26284266,0.20451912,0.0027874922,0.002168586,0.003173874,General Practice
CMP_301,rep_visit,C0300,thyroid disorder woman hormone disease hypothyroidism association pregnancy tsh level,0,0.96530896,0.0039989194,0.0027742772,0.0034718162,0.003702518,0.0046581393,0.0040436042,0.004128723,0.0032120233,0.0047010146,Endocrinology
CMP_302,social-event,C0301,thyroid disorder woman hormone disease hypothyroidism association pregnancy tsh level,0,0.9853931,0.0016837713,0.001168127,0.0014618302,0.0015589688,0.0019613428,0.0017025853,0.001738425,0.0013524429,0.0019793895,Endocrinology
CMP_303,in-person,C0302,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.00046042664,0.0006720741,0.00046625588,0.00058348704,0.4517147,0.00078286446,0.0006795839,0.54331076,0.00053982524,0.00079007016,General Practice
CMP_304,webinar,C0303,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.06901355,0.0021912586,0.0015202,0.0019024255,0.0020288413,0.002552484,0.0022157438,0.9142394,0.0017600687,0.0025759854,General Practice
CMP_305,email,C0304,thyroid disorder woman hormone disease hypothyroidism association pregnancy tsh level,0,0.90899944,0.01048986,0.0072774105,0.009107176,0.009712347,0.012219077,0.010607074,0.010830354,0.008425695,0.012331545,Endocrinology
CMP_306,social-event,C0305,thyroid disorder woman hormone disease hypothyroidism association pregnancy tsh level,0,0.44579655,0.3487852,0.0018730132,0.0023439466,0.0024997017,0.003144876,0.0027299812,0.1874844,0.0021685513,0.0031738232,Endocrinology
CMP_307,webinar,C0306,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.002408582,0.003515753,0.0024390758,0.003052335,0.0032551622,0.0040953164,0.003555038,0.0036298733,0.9699158,0.0041330215,General Practice
CMP_308,email,C0307,thyroid disorder drug infection role include relate adverse function gut,4,0.07764467,0.0007802507,0.00054130406,0.0006774047,0.6727154,0.00090887456,0.0007889692,0.24439922,0.0006267151,0.00091723923,Internal Medicine
CMP_309,in-person,C0308,thyroid disorder woman hormone disease hypothyroidism association pregnancy tsh level,0,0.54752654,0.08275813,0.00034624792,0.00043330534,0.21510944,0.0005813669,0.0005046683,0.00051529164,0.0004008815,0.15182416,Endocrinology
CMP_310,webinar,C0309,thyroid disorder drug infection role include relate adverse function gut,4,0.0010338124,0.0015090321,0.001046901,0.0013101242,0.7125709,0.14085989,0.001525894,0.0015580147,0.13681147,0.001773973,Internal Medicine
CMP_311,in-person,C0310,risk age factor high year disease prevalence associate cardiovascular group,6,0.0027396202,0.0039989604,0.002774305,0.003471851,0.003702555,0.004658185,0.6719039,0.0041287644,0.2979208,0.0047010593,General Practice
CMP_312,webinar,C0311,risk age factor high year disease prevalence associate cardiovascular group,6,0.00070474704,0.06656585,0.00071366946,0.23315176,0.0009524549,0.0011982836,0.4552809,0.13061255,0.00082627754,0.1099935,General Practice
CMP_313,webinar,C0312,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.0011878501,0.0017338776,0.0012028889,0.985276,0.0016053615,0.0020197062,0.001753252,0.001790158,0.0013926896,0.002038295,Family Medicine
CMP_314,in-person,C0313,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.00036374503,0.0005309502,0.00036835021,0.052300464,0.0004915959,0.0006184767,0.0005368832,0.0005481846,0.00042647126,0.9438149,Cardiology
CMP_315,rep_visit,C0314,health care healthcare self model include factor intervention management medical,1,0.0012243708,0.9850588,0.001239872,0.0015516141,0.0016547187,0.002081801,0.0018071559,0.001845197,0.0014355083,0.0021009622,Family Medicine
CMP_316,social-event,C0315,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.02579997,0.03765961,0.026126608,0.032695647,0.034868266,0.043867666,0.03808042,0.68638134,0.030249061,0.04427142,General Practice
CMP_317,social-event,C0316,health care healthcare self model include factor intervention management medical,1,0.0004170521,0.99491066,0.00042233217,0.00052851957,0.0005636396,0.00070911477,0.00061556365,0.0006285214,0.00048897095,0.0007156413,Family Medicine
CMP_318,email,C0317,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.00075840845,0.0011070315,0.0007680103,0.740768,0.15025349,0.0012895266,0.0011194015,0.0011429652,0.0008891927,0.10190391,Family Medicine
CMP_319,in-person,C0318,health care healthcare self model include factor intervention management medical,1,0.0016924543,0.9793467,0.0017138815,0.0021448045,0.0022873264,0.002877684,0.0024980411,0.0025506255,0.0019843106,0.0029041753,Family Medicine
CMP_320,rep_visit,C0319,thyroid disorder drug infection role include relate adverse function gut,4,0.0012632778,0.0018439776,0.40623143,0.0016009201,0.57949513,0.0021479588,0.0018645822,0.0019038323,0.0014811247,0.0021677252,Internal Medicine
CMP_321,webinar,C0320,treatment use respiratory cancer type therapy clinical need care obesity,2,0.0029422212,0.0042946925,0.69698626,0.0037286025,0.0039763674,0.0050026835,0.0043426813,0.004434095,0.0034495946,0.2708428,General Practice
CMP_322,email,C0321,health care healthcare self model include factor intervention management medical,1,0.00042597254,0.6344219,0.00043136554,0.3609197,0.0005756954,0.0007242829,0.00062873005,0.0006419651,0.00049942965,0.00073094876,Family Medicine
CMP_323,in-person,C0322,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.00024071749,0.00035136982,0.00024376508,0.30170614,0.00032532605,0.61372936,0.00035529604,0.00036277517,0.00028222817,0.08240297,General Practice
CMP_324,in-person,C0323,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.00040029545,0.0005843021,0.0004053634,0.05917974,0.00054099323,0.936539,0.00059083104,0.0006032682,0.00046932467,0.0006868888,General Practice
CMP_325,social-event,C0324,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.0029419377,0.004294279,0.29729947,0.6692127,0.003975984,0.005002187,0.004342263,0.0044336687,0.0034492621,0.0050482326,Family Medicine
CMP_326,email,C0325,health care healthcare self model include factor intervention management medical,1,0.0052820314,0.93554246,0.0053489045,0.0066937846,0.0071385857,0.008981082,0.007796212,0.007960323,0.0061928947,0.009063724,Family Medicine
CMP_327,social-event,C0326,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0015011387,0.002191178,0.0015201438,0.4119192,0.0020287663,0.5720257,0.0022156616,0.002262302,0.0017600035,0.0025758834,General Practice
CMP_328,webinar,C0327,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.025799971,0.037659615,0.02612661,0.032695647,0.034868266,0.04386767,0.03808042,0.6863813,0.030249063,0.044271424,General Practice
CMP_329,email,C0328,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.0027396912,0.0039990647,0.0027743771,0.28706282,0.0037026515,0.0046583093,0.00404375,0.683106,0.003212139,0.0047011827,General Practice
CMP_330,in-person,C0329,health care healthcare self model include factor intervention management medical,1,0.00035406562,0.5618621,0.00035854825,0.24672212,0.00047851432,0.18814576,0.00052259635,0.0005335972,0.0004151227,0.00060756016,Family Medicine
CMP_331,rep_visit,C0330,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.02579997,0.03765961,0.026126608,0.032695647,0.034868266,0.043867666,0.03808042,0.68638134,0.030249061,0.04427142,General Practice
CMP_332,in-person,C0331,thyroid disorder drug infection role include relate adverse function gut,4,0.0024084502,0.0035155595,0.18243584,0.0030521678,0.7903518,0.004095096,0.0035548422,0.003629672,0.0028237768,0.004132798,Internal Medicine
CMP_333,email,C0332,treatment use respiratory cancer type therapy clinical need care obesity,2,0.00034485885,0.00050338253,0.9956375,0.0004370309,0.00046607153,0.00058636407,0.00050900737,0.000519722,0.00040432825,0.0005917623,General Practice
CMP_334,in-person,C0333,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.000450044,0.0006569189,0.21727082,0.15164375,0.0006082277,0.00076521205,0.018859109,0.33505622,0.0005276521,0.27416208,General Practice
CMP_335,in-person,C0334,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.00060796307,0.1288449,0.13510677,0.3633647,0.00082165294,0.3676844,0.0008973459,0.00091623527,0.0007128036,0.0010432368,General Practice
CMP_336,email,C0335,risk age factor high year disease prevalence associate cardiovascular group,6,0.0004500245,0.0006568905,0.000455722,0.0005703047,0.0006082013,0.00076517777,0.9945156,0.0006782126,0.0005276292,0.0007722243,General Practice
CMP_337,social-event,C0336,thyroid disorder drug infection role include relate adverse function gut,4,0.00176752,0.0025800085,0.0017898977,0.33481166,0.6456677,0.0030053258,0.0026088369,0.0026637542,0.002072321,0.0030329793,Internal Medicine
CMP_338,in-person,C0337,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.0008945881,0.0013058096,0.00090591406,0.5404246,0.27655014,0.17466646,0.001320401,0.0013481956,0.001048856,0.0015350702,Family Medicine
CMP_339,email,C0338,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.00044011086,0.00064241973,0.06786813,0.21685809,0.15104486,0.00074832316,0.0006495981,0.00066327245,0.000516006,0.5605692,Cardiology
CMP_340,rep_visit,C0339,risk age factor high year disease prevalence associate cardiovascular group,6,0.0021487076,0.003136419,0.0021759113,0.0027230028,0.002903946,0.0036534576,0.6831608,0.0032382263,0.002519243,0.29434028,General Practice
CMP_341,webinar,C0340,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.00041274558,0.052368343,0.00041797114,0.23496373,0.0005578194,0.00070179376,0.28368115,0.00062203134,0.00048392176,0.4257905,Cardiology
CMP_342,in-person,C0341,thyroid disorder drug infection role include relate adverse function gut,4,0.0010077218,0.0014709485,0.00102048,0.316951,0.52555805,0.120283104,0.029279282,0.0015186951,0.001181499,0.0017292064,Internal Medicine
CMP_343,in-person,C0342,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.0005569743,0.0008130027,0.09203166,0.20372114,0.0007527424,0.116511755,0.0008220871,0.00083939236,0.00065302214,0.58329827,Cardiology
CMP_344,email,C0343,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.0003390184,0.00049485744,0.208962,0.3698531,0.22875021,0.00057643437,0.000500387,0.00051092025,0.00039748068,0.18961556,Family Medicine
CMP_345,email,C0344,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.0020387443,0.0029759076,0.0020645559,0.9747286,0.0027553318,0.0034664795,0.0030091603,0.0030725047,0.002390317,0.003498382,Family Medicine
CMP_346,email,C0345,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.0029419488,0.004294296,0.0029791954,0.6108406,0.0039759995,0.35769448,0.0043422803,0.0044336864,0.0034492752,0.005048261,Family Medicine
CMP_347,email,C0346,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.0017675103,0.0025799943,0.0017898878,0.68715745,0.0023887635,0.29393855,0.002608823,0.0026637402,0.0020723096,0.0030329723,Family Medicine
CMP_348,webinar,C0347,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.025799971,0.037659615,0.02612661,0.032695647,0.034868266,0.04386767,0.03808042,0.6863813,0.030249063,0.044271424,General Practice
CMP_349,social-event,C0348,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.0006371115,0.00092997705,0.0006451776,0.54742163,0.00086104654,0.0010832828,0.0009403687,0.0009601634,0.00074697856,0.4457743,Family Medicine
CMP_350,rep_visit,C0349,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.00039243125,0.0005728229,0.00039739962,0.08426718,0.18898897,0.0006672523,0.0005792237,0.14979786,0.0004601043,0.57387674,Cardiology
CMP_351,email,C0350,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.0011535219,0.0016837695,0.0011681261,0.39254466,0.0015589676,0.0019613411,0.001702584,0.5948952,0.0013524418,0.0019793946,General Practice
CMP_352,webinar,C0351,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.00035406617,0.00051682227,0.0003585488,0.35739765,0.00047851508,0.0006020202,0.0005225972,0.00053359795,0.00041512333,0.63882107,Cardiology
CMP_353,social-event,C0352,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.0012632962,0.0018440052,0.30007732,0.0016009434,0.0017073259,0.0021479924,0.16988008,0.051645838,0.0014811462,0.46835202,Cardiology
CMP_354,webinar,C0353,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.025799973,0.037659615,0.026126612,0.03269565,0.03486827,0.043867674,0.038080424,0.6863813,0.030249065,0.04427143,General Practice
CMP_355,email,C0354,thyroid disorder drug infection role include relate adverse function gut,4,0.00091507164,0.001335709,0.0009266569,0.19775458,0.7921393,0.0015558995,0.0013506341,0.0013790654,0.0010728717,0.00157022,Internal Medicine
CMP_356,email,C0355,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.00040436746,0.00059024594,0.3416353,0.00051244465,0.16318572,0.35937378,0.0005968414,0.13253334,0.00047409887,0.00069387525,General Practice
CMP_357,in-person,C0356,health care healthcare self model include factor intervention management medical,1,0.0015011505,0.98168117,0.0015201558,0.0019023702,0.0020287824,0.0025524166,0.002215679,0.0022623197,0.0017600175,0.0025759032,Family Medicine
CMP_358,rep_visit,C0357,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.00041273035,0.000602453,0.0004179557,0.0005230427,0.00055779883,0.9950627,0.00060918473,0.0006220082,0.0004839039,0.0007082256,General Practice
CMP_359,email,C0358,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.0019395709,0.0028311468,0.0019641267,0.5982933,0.0026213008,0.38096252,0.0028627818,0.0029230441,0.0022740415,0.0033282083,Family Medicine
CMP_360,webinar,C0359,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.0052815536,0.007709363,0.0053484207,0.57712823,0.36454186,0.008980259,0.0077955066,0.007959602,0.0061923345,0.00906289,Family Medicine
CMP_361,webinar,C0360,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.00043058733,0.0006285185,0.00043603877,0.1991241,0.31677672,0.00073213014,0.103642285,0.0006489198,0.0005048402,0.3770759,Cardiology
CMP_362,webinar,C0361,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.00033333767,0.00048656535,0.00033755787,0.30792,0.0004505008,0.43171868,0.06748857,0.000502359,0.00039082026,0.19037162,General Practice
CMP_363,in-person,C0362,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.0022712098,0.35167533,0.0022999644,0.0028782466,0.003069506,0.0038617512,0.0033522772,0.6240316,0.00266287,0.0038972888,General Practice
CMP_364,webinar,C0363,health care healthcare self model include factor intervention management medical,1,0.0004170434,0.9949107,0.00042232336,0.0005285085,0.0005636278,0.00070909946,0.0006155507,0.0006285082,0.0004889607,0.0007156267,Family Medicine
CMP_365,rep_visit,C0364,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.00038115148,0.0005563581,0.00038597704,0.9952754,0.00051512045,0.00064807304,0.00056257483,0.00057441706,0.0004468794,0.000654039,Family Medicine
CMP_366,in-person,C0365,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.0007583858,0.0011069984,0.00076798734,0.27002737,0.001024947,0.2519144,0.0011193682,0.0011429312,0.47083628,0.0013013564,General Practice
CMP_367,email,C0366,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.002148811,0.0031365703,0.002176016,0.56869066,0.40757766,0.0036536378,0.0031716193,0.0032383807,0.0025193642,0.0036872602,Family Medicine
CMP_368,email,C0367,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.0014467181,0.0021117413,0.1638341,0.6622012,0.001955218,0.0024598653,0.0021353376,0.002180287,0.0016961984,0.15997934,Family Medicine
CMP_369,email,C0368,thyroid disorder drug infection role include relate adverse function gut,4,0.0031766044,0.004636816,0.0032168217,0.00402563,0.96089166,0.005401189,0.0046886276,0.0047873245,0.003724396,0.005450933,Internal Medicine
CMP_370,social-event,C0369,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.0005205844,0.0007598852,0.00052717526,0.55406785,0.000703562,0.0008851517,0.0007683762,0.0007845505,0.0006103569,0.44037247,Family Medicine
CMP_371,social-event,C0370,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.0016924775,0.0024704705,0.001713905,0.9790208,0.0022873578,0.00287773,0.0024980754,0.0025506616,0.0019843378,0.0029042147,Family Medicine
CMP_372,webinar,C0371,treatment use respiratory cancer type therapy clinical need care obesity,2,0.0025635532,0.00374196,0.59956825,0.0032487263,0.0034646036,0.004358814,0.0037837725,0.0038634227,0.37100792,0.0043989513,General Practice
CMP_373,webinar,C0372,risk age factor high year disease prevalence associate cardiovascular group,6,0.0014466201,0.002111598,0.43442696,0.001833265,0.0019550852,0.0024596923,0.54940826,0.0021801393,0.0016960833,0.002482334,General Practice
CMP_374,rep_visit,C0373,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.00052748347,0.24718156,0.0005341617,0.37174731,0.0007128859,0.0008968821,0.00077855896,0.0007949479,0.0006184457,0.3762078,Cardiology
CMP_375,webinar,C0374,risk age factor high year disease prevalence associate cardiovascular group,6,0.0016924494,0.0024704293,0.0017138767,0.0021447984,0.38117987,0.0028776769,0.60048187,0.0025506197,0.001984305,0.0029041616,General Practice
CMP_376,social-event,C0375,treatment use respiratory cancer type therapy clinical need care obesity,2,0.005281567,0.007709382,0.9331872,0.006693196,0.0071379575,0.008980276,0.0077955257,0.007959622,0.0061923503,0.00906291,General Practice
CMP_377,in-person,C0376,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0025633818,0.0037417093,0.0025958354,0.0032485088,0.003464372,0.96933544,0.0037835198,0.0038631628,0.0030054257,0.00439864,General Practice
CMP_378,email,C0377,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.00041704488,0.0006087508,0.00042232487,0.9948305,0.00056362984,0.0007091028,0.000615553,0.0006285105,0.00048896245,0.00071562885,Family Medicine
CMP_379,rep_visit,C0378,health care healthcare self model include factor intervention management medical,1,0.00037053396,0.45293933,0.0003752251,0.0004695683,0.2829159,0.0006300201,0.09439265,0.00055841595,0.00043443093,0.16691394,Family Medicine
CMP_380,webinar,C0379,risk age factor high year disease prevalence associate cardiovascular group,6,0.00080433197,0.0011740649,0.00081451517,0.4266587,0.0010870425,0.0013676086,0.5645583,0.0012121748,0.00094303547,0.0013802008,General Practice
CMP_381,social-event,C0380,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.001090433,0.0015916805,0.0011042384,0.0013818782,0.0014737039,0.001854066,0.0016094659,0.0016433451,0.0012784734,0.98697275,Cardiology
CMP_382,email,C0381,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.0031765306,0.004636709,0.22391614,0.73992574,0.004293033,0.0054010632,0.004688522,0.0047872127,0.0037243094,0.0054507866,Family Medicine
CMP_383,social-event,C0382,health care healthcare self model include factor intervention management medical,1,0.0011535014,0.9859236,0.0011681053,0.0014618031,0.0015589398,0.0019613039,0.0017025535,0.0017383933,0.0013524177,0.001979355,Family Medicine
CMP_384,rep_visit,C0383,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.02579997,0.03765961,0.026126608,0.032695647,0.034868266,0.043867666,0.03808042,0.68638134,0.030249061,0.04427142,General Practice
CMP_385,webinar,C0384,health care healthcare self model include factor intervention management medical,1,0.0024084668,0.97060907,0.0024389592,0.003052189,0.0032550064,0.0040951236,0.0035548669,0.0036296975,0.0028237964,0.0041328203,Family Medicine
CMP_386,rep_visit,C0385,thyroid disorder drug infection role include relate adverse function gut,4,0.0002939864,0.29804778,0.0002977084,0.25925338,0.3857678,0.0004998662,0.00043392033,0.0004430544,0.00034468307,0.05461782,Internal Medicine
CMP_387,rep_visit,C0386,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.0004500356,0.00065690663,0.00045573324,0.00057031866,0.0006082163,0.0007651972,0.00066424697,0.0006782295,0.00052764226,0.9946234,Cardiology
CMP_388,rep_visit,C0387,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.0005418243,0.00079088844,0.42735702,0.0006866402,0.00073226733,0.00092126604,0.0007997259,0.00081656023,0.00063525955,0.5667185,Cardiology
CMP_389,in-person,C0388,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.004174874,0.42580414,0.00422773,0.52853996,0.0056422795,0.0070985495,0.006162061,0.006291773,0.004894813,0.0071638846,Family Medicine
CMP_390,email,C0389,health care healthcare self model include factor intervention management medical,1,0.00041707454,0.505154,0.00042235487,0.49028492,0.0005636699,0.0007091539,0.0006155968,0.0006285553,0.0004889972,0.00071568124,Family Medicine
CMP_391,rep_visit,C0390,treatment use respiratory cancer type therapy clinical need care obesity,2,0.0004947359,0.00072215457,0.73556423,0.00062696624,0.0006686281,0.00084120117,0.00073022395,0.0007455954,0.0005800509,0.2590262,General Practice
CMP_392,webinar,C0391,thyroid disorder drug infection role include relate adverse function gut,4,0.0010904003,0.0015916321,0.0011042053,0.0013818366,0.9097612,0.0018540121,0.0016094175,0.07845775,0.001278435,0.0018710758,Internal Medicine
CMP_393,webinar,C0392,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.0015599445,0.0022770152,0.21682507,0.0019768781,0.0021082414,0.0026523806,0.0023024587,0.37504536,0.39257586,0.0026767915,General Practice
CMP_394,in-person,C0393,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.00056487514,0.0008245354,0.00057202677,0.91170186,0.00076342025,0.08225665,0.00083374867,0.0008512993,0.0006622854,0.0009692984,Family Medicine
CMP_395,email,C0394,treatment use respiratory cancer type therapy clinical need care obesity,2,0.00046582325,0.0006799515,0.64166784,0.28480765,0.00062955305,0.0007920416,0.00068754936,0.00070202234,0.0005461524,0.0690214,General Practice
CMP_396,email,C0395,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.00039631638,0.00057849387,0.00040133393,0.5746491,0.0005356156,0.00067385775,0.000584958,0.00059727137,0.0004646594,0.42111838,Family Medicine
CMP_397,in-person,C0396,thyroid disorder drug infection role include relate adverse function gut,4,0.0005492907,0.00080178695,0.26430696,0.21553223,0.51465064,0.0009339624,0.0008107461,0.0008278124,0.00064401346,0.0009425579,Internal Medicine
CMP_398,email,C0397,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.02579997,0.03765961,0.026126608,0.032695647,0.034868266,0.043867666,0.03808042,0.68638134,0.030249061,0.04427142,General Practice
CMP_399,email,C0398,health care healthcare self model include factor intervention management medical,1,0.00082085375,0.6756599,0.00083124614,0.31536338,0.0011093714,0.0013957008,0.0012115698,0.0012370738,0.0009624064,0.0014085474,Family Medicine
CMP_400,social-event,C0399,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.00046043444,0.33997685,0.00046626377,0.00058349693,0.0006222702,0.5357826,0.00067959545,0.0006939011,0.0005398344,0.12019477,General Practice
CMP_401,email,C0400,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.116623096,0.0005511191,0.00038234217,0.7508586,0.0005102694,0.0006419712,0.00055727694,0.0005690077,0.000442671,0.1288636,Family Medicine
CMP_402,social-event,C0401,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.00045004528,0.17088418,0.00045574308,0.60906047,0.21574193,0.00076521415,0.0006642612,0.00067824405,0.0005276536,0.00077225734,Family Medicine
CMP_403,in-person,C0402,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.00047131022,0.00068796065,0.00047727724,0.9941578,0.00063696865,0.0008013701,0.000695648,0.0007102916,0.00055258564,0.0008087458,Family Medicine
CMP_404,social-event,C0403,treatment use respiratory cancer type therapy clinical need care obesity,2,0.0009150839,0.0013357268,0.988424,0.0011596626,0.0012367221,0.0015559203,0.0013506523,0.0013790837,0.0010728862,0.0015702411,General Practice
CMP_405,webinar,C0404,thyroid disorder drug infection role include relate adverse function gut,4,0.0010613418,0.0015492166,0.0010747788,0.16901565,0.70460826,0.0018046045,0.0015665273,0.11625407,0.0012443656,0.0018212155,Internal Medicine
CMP_406,in-person,C0405,health care healthcare self model include factor intervention management medical,1,0.00038116923,0.4474082,0.000385995,0.42501193,0.0005151445,0.00064810365,0.123974085,0.0005744439,0.0004469002,0.00065406895,Family Medicine
CMP_407,webinar,C0406,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.00033899568,0.00049482414,0.0003432875,0.99579793,0.00045814752,0.0005763957,0.00050035346,0.0005108859,0.000397454,0.00058170146,Family Medicine
CMP_408,email,C0407,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.00059880014,0.0008740548,0.0006063813,0.9925775,0.0008092694,0.001018141,0.00088382146,0.000902426,0.00070206064,0.0010275121,Family Medicine
CMP_409,social-event,C0408,treatment use respiratory cancer type therapy clinical need care obesity,2,0.025800189,0.037659932,0.673623,0.032695927,0.034868564,0.04386808,0.03808075,0.03888235,0.03024932,0.0442718,General Practice
CMP_410,social-event,C0409,risk age factor high year disease prevalence associate cardiovascular group,6,0.00038114784,0.23239867,0.00038597334,0.000483019,0.0005151155,0.000648067,0.43706307,0.0005744116,0.3268965,0.0006540316,General Practice
CMP_411,rep_visit,C0410,health care healthcare self model include factor intervention management medical,1,0.0009150982,0.66695255,0.0009266838,0.0011596808,0.0012367414,0.0015559451,0.001350674,0.0013791055,0.3229533,0.0015702664,Family Medicine
CMP_412,email,C0411,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.0011878744,0.0017339129,0.0012029134,0.725183,0.0016053942,0.0020197455,0.0017532873,0.0017901943,0.26148537,0.0020383333,Family Medicine
CMP_413,social-event,C0412,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.0016924398,0.0024704158,0.0017138668,0.002144786,0.0022873066,0.18439919,0.30894536,0.11462729,0.37881523,0.0029041506,General Practice
CMP_414,in-person,C0413,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.0029418592,0.004294164,0.121216096,0.0037281439,0.003975878,0.0050020535,0.0043421476,0.004433551,0.84501797,0.005048099,General Practice
CMP_415,social-event,C0414,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.008768047,0.012798517,0.008879054,0.011111523,0.011849883,0.8951119,0.012941525,0.013213949,0.010280058,0.0150455255,General Practice
CMP_416,webinar,C0415,risk age factor high year disease prevalence associate cardiovascular group,6,0.00030523358,0.09129981,0.000309098,0.0003868148,0.00041251854,0.00051898946,0.54978484,0.00046000443,0.3559989,0.00052376674,General Practice
CMP_417,email,C0416,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.0017675086,0.002579992,0.0017898862,0.20940174,0.0023887611,0.0030053013,0.0026088217,0.538035,0.23539008,0.0030329698,General Practice
CMP_418,webinar,C0417,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0010903532,0.0015915635,0.0011041577,0.001381777,0.0014735959,0.65797144,0.0016093478,0.0016432249,0.33026356,0.0018709957,General Practice
CMP_419,social-event,C0418,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0018495369,0.0026997263,0.0018729529,0.0023438712,0.0024996211,0.5537673,0.0027298932,0.0027873574,0.426276,0.0031737192,General Practice
CMP_420,in-person,C0419,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.0003775378,0.45804796,0.0003823176,0.00047844407,0.0005102366,0.0006419286,0.00055724115,0.0005689711,0.53778756,0.0006478374,General Practice
CMP_421,in-person,C0420,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.0009591446,0.40751752,0.00097128784,0.0012154997,0.0012962696,0.0016308371,0.0014156859,0.0014454856,0.58190244,0.0016458473,General Practice
CMP_422,in-person,C0421,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.0011534995,0.0016837365,0.0011681033,0.80046624,0.0015589369,0.001961298,0.0017025508,0.0017383894,0.18658793,0.001979349,Family Medicine
CMP_423,rep_visit,C0422,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.0003419061,0.3193452,0.0003462348,0.00043328892,0.0004620809,0.00058134337,0.0005046491,0.000515272,0.6768833,0.000586695,General Practice
CMP_424,webinar,C0423,health care healthcare self model include factor intervention management medical,1,0.0004450102,0.48015845,0.00045064423,0.00056395016,0.29623333,0.00075665273,0.00065682945,0.000670656,0.2193009,0.0007636171,Family Medicine
CMP_425,rep_visit,C0424,health care healthcare self model include factor intervention management medical,1,0.0016234195,0.8831443,0.0016439728,0.0020573183,0.002194027,0.0027603095,0.0023961472,0.0024465863,0.09894818,0.0027857134,Family Medicine
CMP_426,social-event,C0425,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.00033333362,0.00048655953,0.00033755376,0.00042242525,0.08452873,0.0005667687,0.3489963,0.0005023529,0.563254,0.00057198486,General Practice
CMP_427,webinar,C0426,health care healthcare self model include factor intervention management medical,1,0.0003963158,0.4141991,0.00040133335,0.00050224096,0.0005356148,0.0006738567,0.36393014,0.00059727055,0.21808408,0.0006800591,Family Medicine
CMP_428,email,C0427,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.0016923844,0.0024703345,0.0017138107,0.36205158,0.0022872316,0.0028775653,0.0024979382,0.00255052,0.6189546,0.0029040538,General Practice
CMP_429,rep_visit,C0428,risk age factor high year disease prevalence associate cardiovascular group,6,0.00031996594,0.00046704695,0.00032401687,0.03043468,0.00043242917,0.0005440397,0.5936586,0.00048220722,0.37278795,0.0005490475,General Practice
CMP_430,in-person,C0429,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.0016234859,0.0023697654,0.00164404,0.0020574024,0.0021941166,0.0027604245,0.0023962448,0.0024466873,0.08901008,0.89349777,Cardiology
CMP_431,email,C0430,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.00024819653,0.00036228678,0.00025133882,0.0003145332,0.00033543387,0.00042200935,0.00036633498,0.00037404636,0.9968999,0.0004258935,General Practice
CMP_432,webinar,C0431,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.00035724064,0.16862482,0.00036176346,0.42177948,0.0004828053,0.18264431,0.0005272827,0.0005383821,0.22407092,0.00061300804,Family Medicine
CMP_433,webinar,C0432,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.00058993674,0.0008611172,0.00059740565,0.6576757,0.0007972906,0.0010030706,0.00087073917,0.00088906835,0.3357033,0.0010123027,Family Medicine
CMP_434,email,C0433,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.0013045585,0.0019042338,0.0013210748,0.0016532338,0.001763091,0.28372613,0.0019255122,0.16078912,0.5433745,0.0022385602,General Practice
CMP_435,social-event,C0434,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0041748737,0.0060939677,0.0042277295,0.0052907118,0.005642279,0.63658917,0.006162062,0.0062917727,0.3183636,0.0071638827,General Practice
CMP_436,email,C0435,health care healthcare self model include factor intervention management medical,1,0.0011879173,0.71960723,0.0012029569,0.0015054174,0.0016054522,0.26791632,0.0017533508,0.0017902594,0.0013927685,0.0020384083,Family Medicine
CMP_437,email,C0436,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.00038116626,0.0005563797,0.000385992,0.49231794,0.0005151404,0.2134593,0.0005625966,0.0005744394,0.29059297,0.00065406313,Family Medicine
CMP_438,social-event,C0437,health care healthcare self model include factor intervention management medical,1,0.0003924058,0.87299263,0.00039737383,0.0004972859,0.0005303305,0.00066720875,0.0005791861,0.00059137796,0.1226788,0.00067334954,Family Medicine
CMP_439,email,C0438,risk age factor high year disease prevalence associate cardiovascular group,6,0.00039242388,0.0005728122,0.00039739214,0.00049730885,0.0005303549,0.00066724047,0.65342623,0.00059140543,0.3059234,0.03700143,General Practice
CMP_440,webinar,C0439,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.00034787913,0.11542998,0.00035228347,0.19261476,0.0004701534,0.00059149973,0.33533525,0.0005242738,0.35373697,0.0005969444,General Practice
CMP_441,social-event,C0440,health care healthcare self model include factor intervention management medical,1,0.00036048322,0.50230443,0.0003650471,0.00045683124,0.2441315,0.09973229,0.0005320688,0.000543269,0.15095548,0.0006185733,Family Medicine
CMP_442,in-person,C0441,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.0010903787,0.0015916007,0.0011041834,0.71362317,0.0014736303,0.0018539751,0.0016093854,0.15373316,0.12204944,0.0018710403,Family Medicine
CMP_443,in-person,C0442,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0015011767,0.2099549,0.0015201824,0.0019024032,0.0020288175,0.30120796,0.0022157182,0.28787524,0.18921761,0.002575949,General Practice
CMP_444,social-event,C0443,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.0008946243,0.0013058628,0.00090595067,0.0011337347,0.26357377,0.22316983,0.0013204542,0.0013482501,0.50481236,0.0015351311,General Practice
CMP_445,email,C0444,health care healthcare self model include factor intervention management medical,1,0.00022194714,0.46263573,0.0002247571,0.00028126797,0.0002999582,0.0003773779,0.16460696,0.00033448706,0.37063667,0.0003808518,Family Medicine
CMP_446,social-event,C0445,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0022713118,0.0033153822,0.0023000678,0.002878376,0.0030696443,0.4895314,0.0033524286,0.0034229967,0.4859609,0.0038974578,General Practice
CMP_447,in-person,C0446,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.0003305614,0.00048251284,0.00033474644,0.00041891207,0.00044674872,0.00056205405,0.22846404,0.0004981749,0.76789504,0.0005672282,General Practice
CMP_448,in-person,C0447,health care healthcare self model include factor intervention management medical,1,0.00045517067,0.5239674,0.00046093334,0.0005768262,0.00061515626,0.0007739285,0.2393785,0.0006859682,0.11504944,0.11803666,Family Medicine
CMP_449,email,C0448,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.0003389818,0.0004948039,0.00034327345,0.00042958301,0.00045812872,0.0005763713,0.0005003328,0.00051086483,0.995766,0.00058167597,General Practice
CMP_450,email,C0449,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.00043528128,0.00063537003,0.0327007,0.00055162096,0.41046393,0.00074011076,0.00064246985,0.10789119,0.4451924,0.0007469221,General Practice
CMP_451,in-person,C0450,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.001121041,0.001636358,0.0011352339,0.6235012,0.0015150699,0.051946513,0.0016546428,0.0016894729,0.31387684,0.0019236517,Family Medicine
CMP_452,webinar,C0451,health care healthcare self model include factor intervention management medical,1,0.0037789794,0.7375534,0.003826823,0.0047890046,0.0051072333,0.0064254026,0.0055777254,0.005695137,0.22076172,0.0064845392,Family Medicine
CMP_453,email,C0452,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.00064748264,0.00094511575,0.0006556801,0.40039298,0.00087506295,0.15812993,0.00095567637,0.0009757935,0.4353112,0.0011110508,General Practice
CMP_454,rep_visit,C0453,thyroid disorder woman hormone disease hypothyroidism association pregnancy tsh level,0,0.6278167,0.006093808,0.004227619,0.0052905735,0.005642131,0.0070983595,0.21571714,0.006291609,0.11465835,0.0071637128,Endocrinology
CMP_455,social-event,C0454,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.0012632115,0.0018438806,0.0012792044,0.0016008358,0.0017072111,0.002147839,0.0018644851,0.0019037317,0.984222,0.0021676093,General Practice
CMP_456,email,C0455,thyroid disorder woman hormone disease hypothyroidism association pregnancy tsh level,0,0.88414395,0.0023697831,0.0016440521,0.0020574178,0.002194133,0.0027604399,0.0023962627,0.002446704,0.097201414,0.0027858464,Endocrinology
CMP_457,in-person,C0456,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.00040027846,0.0005842772,0.0004053462,0.00050726277,0.0005409703,0.00068059436,0.000590806,0.0006032425,0.99500036,0.00068685896,General Practice
CMP_458,email,C0457,health care healthcare self model include factor intervention management medical,1,0.00043527893,0.48526844,0.00044078976,0.34632066,0.0005882729,0.10981823,0.0006424662,0.00065599027,0.055082932,0.000746918,Family Medicine
CMP_459,webinar,C0458,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.003176455,0.29326952,0.0032166704,0.0040254407,0.10466011,0.0054009366,0.004688408,0.0047870995,0.5713247,0.005450657,General Practice
CMP_460,webinar,C0459,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.00044501972,0.00064958504,0.00045065387,0.13660692,0.00060143747,0.0007566692,0.310239,0.00067067036,0.54881644,0.0007636343,General Practice
CMP_461,email,C0460,health care healthcare self model include factor intervention management medical,1,0.0020388432,0.63036627,0.002064656,0.0025837743,0.0027554657,0.003466648,0.0030093065,0.0030726527,0.34714383,0.0034985607,Family Medicine
CMP_462,webinar,C0461,risk age factor high year disease prevalence associate cardiovascular group,6,0.0016235966,0.17004931,0.0016441522,0.10956668,0.0021942663,0.0027606061,0.66929483,0.0024468538,0.03763363,0.0027860147,General Practice
CMP_463,email,C0462,thyroid disorder drug infection role include relate adverse function gut,4,0.00060795364,0.00088741607,0.0006156506,0.12510234,0.35487,0.23428634,0.0008973321,0.0009162212,0.28077358,0.0010432209,Internal Medicine
CMP_464,email,C0463,group control risk cardiovascular disease analysis significant blood outcome pressure,9,0.001153517,0.0016837622,0.0011681211,0.0014618229,0.0015589608,0.0019613288,0.0017025768,0.110885404,0.001352436,0.87707204,Cardiology
CMP_465,webinar,C0464,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.0013486927,0.29928327,0.0013657678,0.001709164,0.0018227377,0.3362746,0.0019906536,0.002032557,0.3518583,0.0023142928,General Practice
CMP_466,webinar,C0465,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.00043057697,0.0006285033,0.0004360283,0.6830853,0.0005819183,0.0007321111,0.0006355263,0.0006489042,0.31208232,0.0007388501,Family Medicine
CMP_467,in-person,C0466,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.0046632877,0.006806893,0.004722327,0.005909666,0.0063023623,0.007929002,0.0068829544,0.0070278435,0.6129694,0.33678627,General Practice
CMP_468,in-person,C0467,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.0004947554,0.0007221831,0.00050101924,0.3442314,0.0006686544,0.00084123376,0.0007302528,0.0007456249,0.540572,0.110492945,General Practice
CMP_469,in-person,C0468,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.00031995797,0.07260238,0.00032400878,0.20255981,0.00043241837,0.0005440256,0.15019983,0.00048219503,0.5719864,0.0005490336,General Practice
CMP_470,in-person,C0469,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.00034788146,0.35039753,0.0003522858,0.24067146,0.00047015655,0.00059150404,0.0005134688,0.0005242773,0.40553454,0.0005969487,General Practice
CMP_471,rep_visit,C0470,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.02579997,0.03765961,0.026126608,0.032695647,0.034868266,0.043867666,0.03808042,0.68638134,0.030249061,0.04427142,General Practice
CMP_472,rep_visit,C0471,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.00028556134,0.00041682733,0.00028917668,0.4993709,0.00038593184,0.00048554095,0.22325945,0.00043035732,0.27458623,0.00049000984,Family Medicine
CMP_473,social-event,C0472,risk age factor high year disease prevalence associate cardiovascular group,6,0.000322553,0.00047082332,0.00032663668,0.00040876324,0.00043592553,0.13071768,0.73772234,0.00048610588,0.12855569,0.0005534863,General Practice
CMP_474,rep_visit,C0473,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.00091512664,0.0013357896,0.0009267126,0.0011597169,0.0012367798,0.42642534,0.0013507154,0.0013791485,0.5637004,0.0015703123,General Practice
CMP_475,rep_visit,C0474,risk age factor high year disease prevalence associate cardiovascular group,6,0.00029183505,0.00042598494,0.0002955298,0.00036983515,0.00039441066,0.0004962082,0.80573237,0.00043981217,0.053787354,0.13776667,General Practice
CMP_476,webinar,C0475,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.0024084605,0.30327538,0.0024389527,0.114885636,0.0032549978,0.004095115,0.0035548583,0.0036296875,0.55832416,0.004132803,General Practice
CMP_477,email,C0476,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.00043529234,0.038066067,0.00044080336,0.2318936,0.00058829103,0.088722736,0.0006424861,0.00065601047,0.6378078,0.0007469411,General Practice
CMP_478,webinar,C0477,risk age factor high year disease prevalence associate cardiovascular group,6,0.000455179,0.0006644143,0.00046094175,0.05860207,0.0006151675,0.0007739429,0.44685268,0.054944113,0.43585044,0.0007810658,General Practice
CMP_479,webinar,C0478,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.00027954552,0.00040804624,0.00028308472,0.31793654,0.00037780157,0.2777801,0.0004126058,0.00042129116,0.40162134,0.00047968686,General Practice
CMP_480,in-person,C0479,health care healthcare self model include factor intervention management medical,1,0.0016235673,0.67831826,0.0016441224,0.0020575058,0.0021942265,0.0027605544,0.002396365,0.0024468084,0.3037726,0.0027859635,Family Medicine
CMP_481,in-person,C0480,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.001304662,0.45016918,0.0013211797,0.0016533652,0.001763231,0.0022183196,0.0019256651,0.0019661998,0.53543943,0.0022387414,General Practice
CMP_482,email,C0481,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.00036374564,0.00053095113,0.00036835085,0.00046096565,0.00049159676,0.0006184771,0.37582347,0.0005481855,0.6201701,0.00062417047,General Practice
CMP_483,email,C0482,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.0003604731,0.00052617426,0.00036503686,0.00045681844,0.00048717394,0.0006129138,0.42653862,0.0005432537,0.56949097,0.00061855465,General Practice
CMP_484,rep_visit,C0483,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0007174082,0.0010471845,0.000726491,0.00090915326,0.00096956635,0.66155565,0.0010588856,0.0010811754,0.33070344,0.0012310394,General Practice
CMP_485,social-event,C0484,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.2893931,0.0008017962,0.0005562514,0.0006961102,0.0007423666,0.00093397003,0.00081075565,0.0008278219,0.7042953,0.00094256835,General Practice
CMP_486,rep_visit,C0485,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.00033055668,0.00048250594,0.00033474166,0.0004189061,0.00044674234,0.00056204596,0.23903115,0.0004981678,0.757328,0.0005672195,General Practice
CMP_487,webinar,C0486,health care healthcare self model include factor intervention management medical,1,0.0017675174,0.576797,0.001789895,0.00223993,0.002388773,0.0030053149,0.0026088334,0.0026637497,0.40370598,0.0030329747,Family Medicine
CMP_488,webinar,C0487,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.0015598851,0.0022769282,0.0015796339,0.001976803,0.0021081609,0.0026522751,0.0023023707,0.002350836,0.9805164,0.002676687,General Practice
CMP_489,email,C0488,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.0011535344,0.0016837878,0.0011681386,0.07715734,0.0015589842,0.0019613577,0.29267067,0.0017384422,0.6189284,0.001979411,General Practice
CMP_490,rep_visit,C0489,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.0013959975,0.0020377054,0.0014136714,0.0017691122,0.0018866694,0.12765457,0.0020604748,0.0021038486,0.85728246,0.002395465,General Practice
CMP_491,email,C0490,health care healthcare self model include factor intervention management medical,1,0.00034788295,0.548923,0.00035228732,0.041117765,0.00047015853,0.0005915062,0.0005134709,0.0005242795,0.40656266,0.00059695105,Family Medicine
CMP_492,social-event,C0491,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.0031764884,0.004636647,0.0032167044,0.004025483,0.004292976,0.005400996,0.004688457,0.0047871526,0.96032435,0.0054507093,General Practice
CMP_493,social-event,C0492,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.0006806539,0.16220827,0.0006892713,0.38109168,0.00091989344,0.001157318,0.0010046366,0.0010257844,0.45005456,0.0011679692,General Practice
CMP_494,webinar,C0493,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.0005073026,0.00074049784,0.0005137253,0.0006428917,0.00068561174,0.0008625674,0.00074877235,0.00076453405,0.9936636,0.0008705075,General Practice
CMP_495,in-person,C0494,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.001939509,0.0028310567,0.001964064,0.45830926,0.0026212172,0.003297748,0.0028626912,0.0029229508,0.5199234,0.0033281061,General Practice
CMP_496,webinar,C0495,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.0037788644,0.0055159223,0.0038267067,0.5526101,0.0051070782,0.006425206,0.0055775573,0.005694964,0.4049793,0.006484355,Family Medicine
CMP_497,email,C0496,disease therapy ckd treatment cell risk inflammatory potential systemic effect,7,0.0003419231,0.0004990972,0.000346252,0.04361791,0.00046210387,0.07664409,0.2950456,0.35335538,0.2291009,0.0005867251,General Practice
CMP_498,email,C0497,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0013960516,0.0020377843,0.0014137262,0.0017691808,0.0018867425,0.63175666,0.0020605545,0.00210393,0.35317978,0.0023955558,General Practice
CMP_499,rep_visit,C0498,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0003509608,0.25378454,0.0003554041,0.0004447637,0.0004743182,0.3055987,0.13902691,0.00052891806,0.29883322,0.0006022332,General Practice
CMP_500,email,C0499,vaccination hpv vaccine awareness knowledge covid adult rate cancer health,8,0.00027955722,0.3754287,0.00028309657,0.0003542758,0.00037781737,0.00047533266,0.18047811,0.0004213088,0.44142208,0.0004797074,General Practice
CMP_501,rep_visit,C0500,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0010338023,0.0015090177,0.0010468906,0.0013101114,0.0013971681,0.6680262,0.0015258796,0.0015579995,0.32081896,0.0017739566,General Practice
CMP_502,social-event,C0501,health care healthcare self model include factor intervention management medical,1,0.12219375,0.4694307,0.00050728436,0.0006348314,0.0006770158,0.00085175387,0.00073938456,0.00075494865,0.40335074,0.0008595941,Family Medicine
CMP_503,webinar,C0502,health care healthcare self model include factor intervention management medical,1,0.00087495375,0.47394612,0.0008860311,0.0011088067,0.0011824869,0.43581706,0.0012914209,0.0013186054,0.08207315,0.0015013801,Family Medicine
CMP_504,social-event,C0503,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.0009828052,0.001434578,0.0009952479,0.77008927,0.0013282463,0.0016710683,0.0014506084,0.0014811441,0.10596718,0.114599824,Family Medicine
CMP_505,webinar,C0504,risk age factor high year disease prevalence associate cardiovascular group,6,0.0020387834,0.002975965,0.0020645955,0.0025836986,0.0027553851,0.0034665507,0.8191664,0.003072564,0.15837759,0.0034984557,General Practice
CMP_506,social-event,C0505,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.00035405083,0.00051679986,0.0003585333,0.57181484,0.00047849433,0.00060199335,0.00052257464,0.0005335748,0.4242116,0.0006075345,Family Medicine
CMP_507,email,C0506,management diabetes glucose risk clinical health diabete cardiovascular care insulin,5,0.0015011922,0.002191256,0.0015201981,0.0019024229,0.0020288385,0.4873148,0.09757447,0.0022623825,0.4011285,0.0025759777,General Practice
CMP_508,rep_visit,C0507,health care healthcare self model include factor intervention management medical,1,0.00035406603,0.5161084,0.00035854866,0.00044869888,0.00047851488,0.00060202036,0.00052259694,0.00053359783,0.47998598,0.00060756155,Family Medicine
CMP_509,webinar,C0508,respiratory care disease practice use recommendation clinical pulmonary report year,3,0.0005648749,0.23435588,0.0005720265,0.3719734,0.00076341996,0.00096045964,0.17860195,0.00085129903,0.21038741,0.0009692993,Family Medicine
